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The development of more reactive, general, easily accessible, and readily avail-
able Pd(II)–NHC precatalysts remains a key challenge in homogeneous catalysis.
In this study, we establish air-stable NHC–Pd(II) chloro-dimers, [Pd(NHC)(m-Cl)
Cl]2, as the most reactive Pd(II)–NHC catalysts developed to date. Most crucially,
compared with [Pd(NHC)(allyl)Cl] complexes, replacement of the allyl throw-
away ligand with chloride allows for a more facile activation step, while effec-
tively preventing the formation of off-cycle [Pd2(m-allyl)(m-Cl)(NHC)2] products.
The utility is demonstrated via broad compatibility with amide cross-coupling,
Suzuki cross-coupling, and the direct, late-stage functionalization of pharmaceu-
ticals. Computational studies provide key insight into the NHC–Pd(II) chloro-
dimer activation pathway. A facile synthesis of NHC–Pd(II) chloro-dimers in
one-pot from NHC salts is reported. Considering the tremendous utility of
Pd-catalyzed cross-coupling reactions and the overwhelming success of
[Pd(NHC)(allyl)Cl] precatalysts, we believe that NHC–Pd(II) chloro-dimers,
[Pd(NHC)(m-Cl)Cl]2, should be considered as go-to precatalysts of choice in
cross-coupling processes.
INTRODUCTION
Palladium-catalyzed cross-coupling reactions are among the most powerful molecular assembly tools in
chemistry by enabling facile construction of C–C and C–heteroatom bonds (Molander et al., 2013; Cola-
cot, 2015; Diez-Gonzalez et al., 2009). Tremendous advances have been achieved through the discovery
of tailor-made ligands that facilitate challenging oxidative addition and reductive elimination elementary
steps (Fortman and Nolan, 2011; Martin and Buchwald, 2008). The Pd-catalyzed Suzuki-Miyaura reaction
now ranks as the most frequently executed catalytic transformation in production of pharmaceuticals,
with numerous commercial syntheses of drugs singularly relying on this bond forming technology (Bla-
kemore et al., 2018). Mechanistically, it is now established that achieving high activity of Pd catalysts in-
volves the formation of monoligated Pd(0) species (Christmann and Vilar, 2005). As a result, the develop-
ment of well-defined Pd(0) and Pd(II) precatalysts, wherein Pd and ligand are in a 1:1 ratio, represents a
major direction in catalyst design (Molander et al., 2013; Colacot, 2015; Diez-Gonzalez et al., 2009; Fort-
man and Nolan, 2011; Martin and Buchwald, 2008). In this context, commercially available [Pd(NHC)(allyl)
Cl] (NHC = N-heterocyclic carbene) complexes developed by one of us (S.P.N.) are among the most
powerful and widely used Pd catalysts for various cross-coupling reactions worldwide (Marion et al.,
2006; Hopkinson et al., 2014; Nolan and Cazin, 2017); however, their reactivity is limited by the formation
of off-cycle Pd(I) allyl products (Figures 1A and 1B) (Hruszkewycz et al., 2014; Melvin et al., 2015; Johans-
son Seechurn et al., 2017).
The [Pd(NHC)(allyl)Cl] complexes were first introduced in 2002 (Marion et al., 2006; Viciu et al., 2002a,
2002b). The proposed activation pathway involved a nucleophilic addition to the allyl or the halide
displacement with an alkoxide and reductive elimination to give the active NHC–Pd(0) species. In 2006,
it was established that addition of bulky substituents at the 1-position of the allyl ligands, such as cinnamyl
or prenyl, resulted in a dramatic increase of catalyst efficiency (Marion et al., 2006). In the meantime,
[Pd(NHC)(cin)Cl] (cin = cinnamyl) complexes complexes have become a commercially available class ofiScience 23, 101377, August 21, 2020 ª 2020 The Author(s).
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Figure 1. Pd–NHC Complexes in Cross-Coupling





ArticlePd catalysts of choice for cross-coupling reactions. The use of NHC ancillary ligands expedites the reaction
development owing to the strong s-donating properties of NHC ligands cf. phosphines (Martin and Buch-
wald, 2008; Marion et al., 2006; Hopkinson et al., 2014; Nolan and Cazin, 2017). These [Pd(NHC)(allyl)Cl] cat-
alysts are now available in several forms from various suppliers, facilitating challenging C–C and C–
heteroatom cross-couplings worldwide. It should also be noted that, in addition to Pd(II)–NHC precatalysts
bearing highly effective allyl-type or palladacycle-type throw-away ligands (Figure 1A), heteroatom donors,
including the PEPPSI-class of catalysts, have attracted considerable attention (Chart 1) (Nolan and Cazin,
2017; O’Brien et al., 2006).
In 2014, it was identified that the formation of inactive [Pd2(m-allyl)(m-Cl)(NHC)2] dimers during the activation
of [Pd(NHC)(allyl)Cl] complexes takes place (Figure 1B) (Hruszkewycz et al., 2014). It was established that
the monoligated NHC–Pd(0) species undergoes comproportionation with [Pd(NHC)(allyl)Cl] monomers
to give the inactive allyl-bridged Pd(I) dimers, [Pd2(m-allyl)(m-Cl)(NHC)2]. The extent of formation of this inac-
tive dipalladium complex is dependent on the presence of substituents at the allylic terminal position.
Thus, allyl-type complexes bearing sterically bulky t-Bu-indenyl ligand, [Pd(NHC)(1-t-Bu-ind)Cl], showed
high reactivity by suppressing the formation of the inactive Pd(I) allyl products (Melvin et al., 2015). How-
ever, this class of catalysts still relies on catalyst activation by allyl displacement (cf. dissociation),2 iScience 23, 101377, August 21, 2020




Articlemulti-step synthesis, and the introduction of waste-generating throw-away allyl ligand, which is less than
desirable from the activation-, reactivity-, atom-, step-, and cost-economy perspective.
Over the past years, we have introduced Pd–NHC complexes for the cross-coupling of amides through
oxidative addition of N–C(O) bonds, which is also instrumental for the cross-coupling of bench-stable
esters via acyl-metals from common amides and esters (Shi et al., 2018). In the context, we have studied
Pd–NHC complexes with various throw-away ligands (M.S.) (Lei et al., 2017).
In this study, we establish air-stable NHC–Pd(II) chloro dimers, [Pd(NHC)(m-Cl)Cl]2, as the most reactive
Pd(II)–NHC catalysts developed to date. Most crucially, compared with [Pd(NHC)(allyl)Cl] complexes,
replacement of the allyl throw-away ligand with chloride allows for a more facile activation step, while effec-
tively preventing the formation of off-cycle [Pd2(m-allyl)(m-Cl)(NHC)2] products. These catalysts are highly
reactive, easy to prepare, readily activated to Pd(0)–NHC by dimer dissociation (cf. allyl displacement),
and avoid cost- and waste-generating allyl ligands. The utility of this class of catalysts is demonstrated
via broad compatibility with privileged biaryls and the direct, late-stage functionalization of common phar-
maceuticals. Extensive computational studies provide key insight into the NHC–Pd(II) chloro dimer
activation pathway. With the goal of providing increasingly practical technologies, a facile synthesis of
NHC–Pd(II) chloro dimers in one-pot from NHC salts is reported. Considering the tremendous utility
of Pd-catalyzed cross-coupling reactions in chemical synthesis and the overwhelming success of
[Pd(NHC)(allyl)Cl] precatalysts, we believe that NHC–Pd(II) chloro dimers, [Pd(NHC)(m-Cl)Cl]2, should be
considered as go-to precatalysts of choice in cross-coupling processes.Results and Discussion
Catalytic Studies
Our investigation of the reactivity of NHC–Pd(II) chloro dimers, [Pd(NHC)(m-Cl)Cl]2, was initiated by evalu-
ating the reactivity of a model IPr-based catalyst (IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene)
in the cross-coupling of amide 7 with boronic acids. Somewhat ironically, it is worth noting that the [Pd(IPr)
(m-Cl)Cl]2 catalyst was first reported by one of us (S.P.N.) in 2002; however, at that point the focus was aimed
at the seeminglymore reactive [Pd(NHC)(allyl)Cl] complexes (Viciu et al., 2002a, 2002b; Navarro et al., 2003).
Now, after nearly 20 years in catalyst development (Marion et al., 2006; Shi et al., 2018), we hypothesized that
[Pd(NHC)(m-Cl)Cl]2 complexes might be of great benefit in cross-coupling reactions owing to facile activa-
tion and elimination of the off-cycle products in the absence of problematic allyl throw-away ligands.
Selected optimization results are summarized in Table 1. Full optimization results are presented in the Sup-
plemental Information. After preliminary experiments, we found that the desired cross-coupling occurred
in >98% yield at 0.25 mol% catalyst loading under very mild room temperature conditions (Table 1, entry 3).
Furthermore, the reaction could be successfully performed at 0.050–0.025 mol% catalyst loading (>95%
conversion) by increasing the temperature to 40C (Table 1, entries 7 and 8).
At this point, kinetic profiling studies were conducted to gain insight into the reaction and compare the
reactivity of [Pd(IPr)(m-Cl)Cl]2 with other classes of Pd(II)–NHC catalysts (Figure 2). Crucially, in kinetic
profiling studies, we found that [Pd(IPr)(m-Cl)Cl]2 (6) was a superior catalyst to [Pd(IPr)(cin)Cl] and
[Pd(IPr)(1-t-Bu-ind)Cl] (Marion et al., 2006; Melvin et al., 2015), whereas the heterocycle-based Pd-PEP-
PSI-IPr (10) (O’Brien et al., 2006) (Chart 1) showed the lowest reactivity. It is well known that activation of
Pd-PEPPSI-type catalysts is slow (Hopkinson et al., 2014). However, it should also be noted that, in specific
cases, the rate of catalyst activation might differ between substrates, including cases when substrateiScience 23, 101377, August 21, 2020 3
Entry Catalyst (mol%) Boronic Acid (equiv) Base (equiv) H2O (equiv) Yield
a (%)
1 1.5 1.2 2.0 0 56
2 1.5 1.2 2.0 5 >98
3 0.25 1.05 1.1 5 >98
4 0.05 1.05 1.1 5 32
5b 0.05 2.0 1.1 5 74
6b,c 0.05 2.0 3.0 5 85
7b,d 0.05 2.0 3.0 5 >98
8b,d 0.025 2.0 3.0 5 96
Table 1. Optimization of Pd-Catalyzed Suzuki-Miyaura Cross-Coupling of Amides
Conditions: amide 7a, PhC(O)–NPh/Boc, (1.0 equiv), catalyst ([Pd(IPr)(m-Cl)Cl]2) (x mol%), 4-Tol-B(OH)2 (1.05–2.0 equiv), K2CO3









Articleactivation by nucleophilic addition takes place (Shi et al., 2018). The reaction of amide 7 gave 89% conver-
sion after 4 h using 6 as catalyst, which can be compared with 42% and 25% conversion when using [Pd(IPr)(-
cin)Cl] and [Pd(IPr)(1-t-Bu-ind)Cl] catalysts. Crucially, initial rates revealed that the NHC–Pd(II) chloro dimer
[Pd(IPr)(m-Cl)Cl]2 catalyst gives 3.1 and 4.2 times faster reaction than the cinnamyl- and t-Bu-indenyl-based
catalysts.
Our preliminary studies indicate that sterically hindered imidazolylidene and saturated imidazolinylidene
ligands perform well as ancillary ligands in [Pd(NHC)(m-Cl)Cl]2 complexes. As such, two other chloro dimers
[Pd(NHC)(m-Cl)Cl]2 based on SIPr and IPr* NHC ancillary ligands were prepared and evaluated in the cross-
coupling of amide 7 with 4-Tol-B(OH)2 (see Scheme S1). The reactivity of saturated imidazolinylidene-
based catalyst SIPr (SIPr = 1,3-bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene) (74% yield) and sterically
hindered IPr* (IPr* = 1,3-bis(2,6- bis(diphenylmethyl)4-methylphenyl)imidazol-2-ylidene) (Izquierdo et al.,
2014) (24% yield) at 0.050 mol% loading was identified as promising but provided lower yields than 6.
Our ongoing studies are focused on the development of NHC ligands that can be broadly utilized as sup-
porting ligands in cross-coupling reactions.
The substrate scope of amide bond cross-coupling using the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6
was briefly investigated (Scheme 1). As such, the cross-coupling of electronically varied amides and boronic
acids, including electrophilic functional groups (9e), alkyl amides (9d), and deactivated substrates (9c, 9b0),
could be achieved at room temperature at low catalyst loading in excellent yields. Furthermore, a turnover
number (TON) of 14,800 was calculated for the cross-coupling of amide 7a ([Pd(IPr)(m-Cl)Cl]2 (6), 25 ppm, 4-
Tol-B(OH)2, 120
C, 2-MeTHF). The use of 2-MeTHF is preferred for TON determination owing to much bet-
ter solubility of the base in this solvent (see Scheme S3).
At this stage, we turned our attention to the more synthetically significant biaryl Suzuki-Miayura cross-
coupling. Beyond doubt, the biaryl Suzuki-Miyaura synthesis ranks as the most important and powerful
C–C bond forming cross-coupling reaction discovered to date (Fyfe and Watson, 2017). The impact of
the biaryl Suzuki-Miyaura cross-coupling is clearly illustrated by the change of the shape of bioactive phar-
macophores that are now prepared as medicines and scaffolds in drug discovery enabled by the emer-
gence of this cross-coupling technology (Yet, 2018).
Our initial optimization focused on two standard conditions that are routinely applied in the development
of Suzuki-Miyaura cross-coupling, namely, the much preferred conditions using weak base (K2CO3) and the
alternative conditions using strong base (KOt-Bu) (see Table S1). Crucially, the NHC–Pd(II) chloro dimer
[Pd(IPr)(m-Cl)Cl]2 6 promoted the model cross-coupling of 4-chlorotoluene with Ph–B(OH)2 in quantitative
yield under both conditions in EtOH as a solvent.4 iScience 23, 101377, August 21, 2020
Figure 2. Kinetic Profile of Suzuki-Miyaura Cross-Coupling of Amides
Conditions: 7a (PhCONBocPh), 4-Tol-B(OH)2 (2.0 equiv), catalyst ([Pd(IPr)(m-Cl)Cl]2, 0.05 mol%; other catalysts, 0.10 mol





ArticleNext, kinetic profiling studies revealed the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6 is a superior catalyst
to [Pd(IPr)(1-t-Bu-ind)Cl] under the much preferred mild base conditions using K2CO3 (orange triangles
versus red triangles, Figure 3) consistent with facile activation by dimer dissociation. Interestingly, the reac-
tivity of 6 is similar to [Pd(IPr)(1-t-Bu-ind)Cl] under KOt-Bu conditions (green squares versus blue squares,
Figure 3). It is also worth noting that K2CO3 is the preferred base in case of selected substrates (see
Schemes S5 and S6). We have further evaluated the comparative reactivity of the NHC–Pd(II) chloro dimer
[Pd(IPr)(m-Cl)Cl]2 6 and [Pd(IPr)(1-t-Bu-ind)Cl] in the cross-coupling of electron-rich and sterically hindered
substrates, wherein 6 also showed better reactivity. Our preliminary studies indicate that [Pd(NHC)(m-Cl)
Cl]2 catalysts are efficient in cross-coupling of sterically hindered 2,6-di-substituted aryl chlorides (see
Scheme S6). Our future studies will focus on expanding the scope of reactions enabled by [Pd(NHC)
(m-Cl)Cl]2 catalysts.
With the knowledge that the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6 is a highly effective catalyst oper-
ating under mild, synthetically useful conditions, we next investigated the synthetic scope of 6 with a focus
on compatibility with privileged biaryls and the direct, late-stage functionalization of common drugs
(Schemes 2, 3, and 4).
As outlined in Schemes 2 and 3, the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6 can be deployed success-
fully with a remarkably broad range of aryl chlorides and boronic acids (Afagh and Yudin, 2010). Most
crucially, the highlighted functional groups are among the most commonly encountered in pharmaceuti-
cals and allow for further functionalization by traditional or orthogonal cross-coupling methods (Blakemore
et al., 2018). A variety of synthetically useful substituents is tolerated, including nitriles; unprotected hy-
droxyl; free amines; pyridines; esters; free indoles; triazines; benzofurazans; aldehydes; free carboxylic
acids; dioxolanes; polyfluorinated substrates; Boc-protected amines; NH-benzamides; pyridazines; pri-
mary, secondary, tertiary amides; sulfonamides; 2,1,3-benzothiadiazoles; pyrazines; bis-heterocycles; py-
rimidines; functionalized indoles; benzotriazoles; and pyrroles, enabling the synthesis of privileged biaryl
motifs in excellent yields. When aryl chlorides gave lower conversion or are not easily available, aryl bro-
mides could be used successfully.
Furthermore, the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6 could be readily deployed in the direct cross-
coupling of densely functionalized pharmaceuticals (Scheme 4), such as Fenofibrate, Haloperidol, Indo-
methacin, Chlorpromazine, Glibenclamide, Griseofulvin, and Chloroquine, thus clearly demonstrating
the potential impact on the synthesis and potential late-stage further derivatization of complex biaryls iniScience 23, 101377, August 21, 2020 5
Scheme 1. Scope of Amide Suzuki-Miyaura Cross-Coupling
Conditions: amide (1.0 equiv), Ar-B(OH)2 (2.0 equiv), [Pd(IPr)(m-Cl)Cl]2, 0.25 mol%, K2CO3 (3.0 equiv), H2O (5 equiv),





Articlepharmaceutical settings. The selected substrates further demonstrate the functional group tolerance with
respect to privileged motifs that are broadly present in pharmaceutical development.
Preliminary studies using the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6 indicated that the cross-coupling
at 25 ppm catalyst loading is also feasible using K2CO3 as a mild carbonate base (see Scheme S7). To our
knowledge, these results establish the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6 as themost active Pd(II)–
NHC catalysts discovered to date and a major improvement over the overwhelmingly successful
[Pd(NHC)(allyl)Cl] catalysts. The use of the commonly available IPr ligand and the commercial availability
on large scale (i.e., kg scale) surely make the NHC–Pd(II) chloro dimer [Pd(IPr)(m-Cl)Cl]2 6 an attractive
tool to be used in small- and larger-scale molecular assembly cross-coupling strategies.Mechanism Studies
To gain further insight into the reactivity of the palladium halide dimer catalysts, [Pd(NHC)(m-X)X]2, we pre-
pared the bromo- and iodo-based congeners, [Pd(IPr)(m-Br)Br]2 and [Pd(IPr)(m-I)I]2, and evaluated their
reactivity in the model Suzuki cross-coupling (see Table S2). The bromo dimer showed slightly lower reac-
tivity than the chloro relative, whereas the iodo dimer was completely unreactive across electronically and
sterically differentiated substrates at room temperature; however, moderate conversion was observed at
60C. This establishes the reactivity order of the halide dimer catalysts: Cl > Br > I, which is consistent
with the activation of [Pd(NHC)(m-X)X]2 halide dimer catalysts to yield the active, monoligated NHC–
Pd(0) complex (Fairlamb et al., 2006).
To further understand the high reactivity of 6, wemeasured the activation rate to themonoligated IPr–Pd(0)
(Scheme 5). The rate was measured in the presence of dvds (dvds = 1,3-divinyl-1,1,3,3-tetramethyldisilox-
ane) and base (Hruszkewycz et al., 2014). We found that, in a comparison between [Pd(IPr)(allyl)Cl], [Pd(IPr)(-
cin)Cl], and [Pd(IPr)(m-Cl)Cl]2 (6), the allyl complex is activated the fastest (kobs = 1.1 * 10
3 s1), whereas the
chloro dimer (kobs = 7.0 * 10
4 s1) was activated faster than the cinnamyl complex (kobs = 3.0 * 10
4 s1) (see
Scheme S8). The absence of an allyl moiety in 6 obviously excludes a decomposition route leading to
bridged-allyl dinuclear palladium complexes. The high activation rate of [Pd(IPr)(m-Cl)Cl]2 is consistent
with the excellent activity of this catalyst in cross-coupling.Computational Analysis of [(IPr)Pd(m-Cl)Cl]2 Activation
DFT studies (M06/Def2TZVP  SDD//BP86-d3(PCM,THF)/SVP  SDD) were conducted to gain insight into
the exact activation pathway employed by 6 and compare it with those of other classes of air-stable Pd(II)6 iScience 23, 101377, August 21, 2020
Figure 3. Kinetic Profile of Biaryl Suzuki-Miyaura Cross-Coupling of Aryl Chlorides
Conditions: 13a (4-Tol-Cl), Ph-B(OH)2 (1.05 equiv), catalyst ([Pd(IPr)(m-Cl)Cl]2, 0.50 mol%; [Pd(IPr)(1-t-Bu-ind)Cl], 1.0 mol%),





Articleprecatalysts (Data S1, Cartesian coordinates and energies, related to Figure 4). From catalyst 6, via a bar-
rierless step (checked by a linear transit), the simple cleavage of the dimer requires 17.6 kcal/mol, thus
affordable at room temperature. Analyzing the halide that holds together the dimer structure, calculations
validated the results found in the reactivity order of the halide dimer catalysts (see Table S2), with higher
thermodynamic cost for the dimer cleavage of 2.1 and 10.5 kcal/mol for Br and I, respectively. The latter
value is in perfect agreement with experiments and confirms the activity at 60C and the poorer results
at rt. Second, the analysis moved to the different NHC ligands that occupy different space around the
metal. The mechanism to activate catalysts 6, 11, and 12, i.e., that leads to the active catalytic Pd(0) species,
is included in Figure 4. The computed values for the barrierless dimer cleavage are 17.6 (IPr), 16.8 (SIPr), and
26.5 (IPr*) kcal/mol, thus becoming unfavored for larger NHC ligands (Falivene et al., 2016, 2019). The
higher energy cost for the cleavage of 12 is in agreement with experimental results (see Scheme S1), ex-
plaining the poor performance of the sterically very encumbered 12 at rt, but much improved activity at
more elevated temperatures.
Post dimer cleavage, we envisaged that Ph-B(OH)2 together with the base K2CO3 must assist in the
displacement/removal of one of the halides and deliver a phenyl ligand. This hypothesis is supported by
results in Table 1 where better catalytic performance is obtained with an excess of boronic acid. After
the first rearrangement caused by the entering K2CO3, the Ph-B(OH)2 bonds to the ionic KCO3 moiety,
and the aryl group on boron is transferred to the palladium in the e/f step with an energetic cost of
21.7, 22.1, and 22.4 kcal/mol for 6, 11, and 12, respectively, calculated not from intermediate d, but c as
a reference. In the absence of base, the aryl transfer to the metal shows an increase in the energy barrier
for 6 of 18.2 kcal/mol. Next, there is the favorable thermodynamic dissociation of the K2CO3ClB(OH)2 moi-
ety, followed by a second coordination of a base that in combination of a second Ph-B(OH)2 moiety allows
the aryl transfer from boron to palladium (see Figure 5). The kinetic requirement of the latter j/k step is
23.3, 24.6, and 23.6 kcal/mol for 6, 11, and 12, respectively, calculated from intermediate i. In the precata-
lyst activation sequence, this latter step becomes the rate determining step (rds) for 6 and 11, whereas for
12 this remains the halide bond cleavage of the dimer. Finally, once the K2CO3ClB(OH)2 moiety is released,
the two aryl groups bound to palladium eliminate and form biphenyl and yield a Pd(0) species. Alterna-
tively, instead of involving a second equivalent of base, the release of chlorobenzene from the initially
formed [Pd(NHC)(Ph)Cl] was studied. This reductive elimination was found to be not kinetically facile,
with an energy barrier of 22.4 kcal/mol, together with a thermodynamic cost of 18.1 kcal/mol (see Figure S1).
Using the Pd(0) species for the acyl Suzuki-Miyaura cross-coupling of amides by N–C(O) cleavage has been
previously shown to involve upper energy barriers of 23.8 and 26.5 kcal/mol for catalysts 6 and 12 (Li et al.,
2018), thus mirroring the same trend as in the pre-activation of the corresponding catalysts.iScience 23, 101377, August 21, 2020 7
Scheme 2. Scope of Pd-Catalyzed Biaryl Suzuki-Miyaura Cross-Coupling





ArticleWealso compared the energetics for the dimeric 6with those for themonomeric 1 and 2 leading to the Pd(0)
species (see Figure S2). Even though the kinetics require just 25.3 and 23.3 kcal/mol for 1 and 2, respectively,
generation of an active species is hindered by the starting metal catalyst since formation of a bridged allyl
dipalladium is highly favored by 17.4 and 14.3 kcal/mol. And this forces a kinetic requirement of 30.9 and
27.2 kcal/mol to recover the Pd(0) species. Thus, the catalyst itself with the off-cycle intermediate blocks
the formation of the catalytic active species Pd(0) at mild temperature, contrarily to what happens with sim-
ple halide bridged catalysts 6, 11, and even 12, studied here. Not having any allyl or substituted allyl sup-
porting ligand appears to represent the simplest solution to avoiding catalyst deactivation.One-Pot Synthesis of [Pd(IPr)(m-Cl)Cl]2
Our catalytic experiments clearly indicated the excellent activity of the NHC–Pd(II) chloro dimer [Pd(IPr)(m-
Cl)Cl]2 6. To provide practical synthetic technologies to practitioners, we developed a facile one-pot syn-
thesis of NHC–Pd(II) chloro dimers from NHC salts (Scheme 6). As such, the air-stable NHC–Pd(II) chloro
dimer [Pd(IPr)(m-Cl)Cl]2 6 could be readily prepared both on a small scale (0.11 mmol, ca. 60 mg) or on a
preparative gram scale (3.7 mmol, 1.69 g) in 81% yield. The rapid availability of 6 compares very favorably
with other Pd(II)–NHC precatalysts (note that 6 is also already commercially available) and should provide
facile access to this class of catalysts for various cross-coupling technologies as well as for a plethora of
other catalytic reactions that require monoligated Pd complexes, including C–H activation and hydrofunc-
tionalization processes (Hopkinson et al., 2014; Nolan and Cazin, 2017).8 iScience 23, 101377, August 21, 2020
Scheme 3. Scope of Pd-Catalyzed Biaryl Suzuki-Miyaura Cross-Coupling
Conditions: Ar-X (1.0 equiv), Ar-B(OH)2 (2.0 equiv), K2CO3 (3.0 equiv), [Pd(IPr)(m-Cl)Cl]2 (6) (y mol %), EtOH (0.50 M), 12 h. Isolated yields.
aAr-B(OH)2 (3.0





In summary, we have established air-stable NHC–Pd(II) chloro dimers, [Pd(NHC)(m-Cl)Cl]2, as the most reac-
tive Pd(II)–NHC catalysts developed to date. The key feature of this class of catalysts is that replacement of
the allyl throw-away ligand from the overwhelmingly successful [Pd(NHC)(allyl)Cl] complexes by a bridging
chloride imparts a facile activation by dissociation, prevents the formation of off-cycle allyl products, and
eliminates synthetic and economic technological issues associated with allyl ligands. These catalysts are
highly reactive, easy to prepare, readily activated to Pd(0)–NHC by dimer dissociation (cf. allyl displace-
ment), and avoid cost- and waste-generating allyl ligands. The utility of this class of catalysts has been
demonstrated in the synthesis of privileged biaryls and the direct, late-stage functionalization of pharma-
ceuticals, showing excellent functional group tolerance and chemoselectivity. Computational studies pro-
vided key insight into the NHC–Pd(II) chloro dimer activation pathway and rationalized the superior cata-
lytic performance of the dimer catalysts compared with that of the allyl and substituted-allyl palladium
catalysts. Crucially, a facile, one-pot synthesis of NHC–Pd(II) chloro dimers has been developed, thus
enabling simple and scalable access to [Pd(NHC)(m-Cl)Cl]2 complexes. Overall, the scope of the reactions
catalyzed by [Pd(NHC)(m-Cl)Cl]2 complexes supersedes other classes of Pd–NHC catalysts, including acti-
vation, rate of cross-coupling of model substrates in different reaction classes, and catalyst synthesis. Our
future studies will be focused on expanding the range of transformations mediated by [Pd(NHC)(m-Cl)Cl]2
complexes.
Considering the tremendous impact of Pd-catalyzed cross-coupling reactions in chemical synthesis and the
tremendous success of [Pd(NHC)(allyl)Cl] precatalysts by practitioners worldwide, we believe that NHC–Pd(II)
chloro dimers, [Pd(NHC)(m-Cl)Cl]2, should be routinely considered as go-to precatalysts of choice in cross-iScience 23, 101377, August 21, 2020 9
Scheme 4. Direct Cross-Coupling of Pharmaceuticals
Conditions: Ar-X (1.0 equiv), Ar-B(OH)2 (2.0 equiv), K2CO3 (3.0 equiv), [Pd(IPr)(m-Cl)Cl]2 (6) (y mol %), EtOH (0.50 M), 12 h. Isolated yields.
aiPrOH. bK2CO3 (5




Articlecoupling processes. The exceptional performance of [Pd(NHC)(m-Cl)Cl]2 catalysts provides a strong founda-
tion to accelerate applications in the synthesis of medicines, organic molecules, and polymers.Limitations of the Study
Limitations are typical to NHC-based catalyst systems and include lower efficiency for highly sterically hin-
dered substrates using IPr ligand and high reaction temperature using ppm catalyst levels. Our future
studies will focus on the development of more active ligands and catalysts to expand the scope of appli-
cation of Pd–NHC catalysis.Resource Availability
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by
the Lead Contact, Michal Szostak (michal.szostak@rutgers.edu).
Materials Availability
This study did not generate new unique reagents.Scheme 5. Rates of Activation of Allyl, Cinnamyl and Chloro Dimer, [(NHC)Pd(m-Cl)Cl]2, Complexes
Conditions: Pd–NHC (1.0 equiv), KOt-Bu (10 equiv), dvds (10 equiv), MeOH-d4, 23
C, 0–3 h.
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Figure 4. DFT-Optimized Pathway (Relative Energies to Pd(0) in kcal/mol) for the Activation of Catalysts 6




ArticleData and Code Availability
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Figure 5. DFT-Optimized Transition State of the Second Aryl Transfer from Boron to Palladium for 6 (left) and 12
(right); Main Distances Are Given in Å
Scheme 6. Facile, One-Step Synthesis of 6
Conditions: IPrHCl (1.0 equiv, 3.7 mmol), Pd(OAc)2 (1.2 equiv), K2CO3 (4 equiv), toluene, 80
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Figure	   S1.	   Full	   DFT-­‐optimized	   pathway	   (relative	   energies	   to	   Pd(0)	   in	   kcal/mol)	   for	   the	  
activation	  of	  catalysts	  6	  (black),	  11	  (red)	  and	  12	  (blue);	  including	  the	  release	  of	  PhCl	  and	  











































































































































































































Figure	  S2.	  DFT-­‐optimized	  pathway	  for	  the	  activation	  of	  catalysts	  1	  and	  2	  (relative	  energies	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Figure	  S3.	  1H	  NMR	  spectrum	  of	  phenyl(p-­‐tolyl)methanone,	  related	  to	  Scheme	  1	  
Figure	  S4.	  13C	  NMR	  spectrum	  of	  phenyl(p-­‐tolyl)methanone,	  related	  to	  Scheme	  1	  
	  
Figure	  S5.	  1H	  NMR	  spectrum	  of	  (4-­‐methoxyphenyl)(phenyl)methanone,	  related	  to	  
Scheme	  1	  
Figure	  S6.	  13C	  NMR	  spectrum	  of	  (4-­‐methoxyphenyl)(phenyl)methanone,	  related	  to	  
Scheme	  1	  
	  
Figure	  S7.	  1H	  NMR	  spectrum	  of	  phenyl(4-­‐(trifluoromethyl)phenyl)methanone,	  related	  to	  
Scheme	  1	  






























Figure	  S11.	  13C	  NMR	  spectrum	  of	  1-­‐phenyldecan-­‐1-­‐one,	  related	  to	  Scheme	  1	  
	  
Figure	  S12.	  1H	  NMR	  spectrum	  of	  methyl	  4-­‐benzoylbenzoate,	  related	  to	  Scheme	  1	  
Figure	  S13.	  13C	  NMR	  spectrum	  of	  methyl	  4-­‐benzoylbenzoate,	  related	  to	  Scheme	  1	  
	  
	  
Figure	  S14.	  1H	  NMR	  spectrum	  of	  phenyl(o-­‐tolyl)methanone,	  related	  to	  Scheme	  1	  
Figure	  S15.	  13C	  NMR	  spectrum	  of	  phenyl(o-­‐tolyl)methanone,	  related	  to	  Scheme	  1	  
	  
Figure	  S16.	  1H	  NMR	  spectrum	  of	  4-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S17.	  13C	  NMR	  spectrum	  of	  4-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
	  
Figure	  S18.	  1H	  NMR	  spectrum	  of	  4-­‐methoxybiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S19.	  13C	  NMR	  spectrum	  of	  4-­‐methoxybiphenyl,	  related	  to	  Scheme	  2	  
	  
	  
Figure	  S20.	  1H	  NMR	  spectrum	  of	  4'-­‐methoxy-­‐2,6-­‐dimethylbiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S21.	  13C	  NMR	  spectrum	  of	  4'-­‐methoxy-­‐2,6-­‐dimethylbiphenyl,	  related	  to	  Scheme	  2	  
	  
Figure	  S22.	  1H	  NMR	  spectrum	  of	  4-­‐cyano-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S23.	  13C	  NMR	  spectrum	  of	  4-­‐cyano-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
	  
	  
Figure	  S24.	  1H	  NMR	  spectrum	  of	  4-­‐hydroxy-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S25.	  13C	  NMR	  spectrum	  of	  4-­‐hydroxy-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
	  
Figure	  S26.	  1H	  NMR	  spectrum	  of	  4-­‐amino-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S27.	  13C	  NMR	  spectrum	  of	  4-­‐amino-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
	  
Figure	  S28.	  1H	  NMR	  spectrum	  of	  2-­‐amino-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S29.	  13C	  NMR	  spectrum	  of	  2-­‐amino-­‐4'-­‐methylbiphenyl,	  related	  to	  Scheme	  2	  
	  
Figure	  S30.	  1H	  NMR	  spectrum	  of	  2-­‐(p-­‐tolyl)pyridine,	  related	  to	  Scheme	  2	  
Figure	  S31.	  13C	  NMR	  spectrum	  of	  2-­‐(p-­‐tolyl)pyridine,	  related	  to	  Scheme	  2	  
	  
Figure	  S32.	  1H	  NMR	  spectrum	  of	  3-­‐(6-­‐methoxynaphthalen-­‐2-­‐yl)pyridine,	  related	  to	  Scheme	  2	  
Figure	  S33.	  13C	  NMR	  spectrum	  of	  3-­‐(6-­‐methoxynaphthalen-­‐2-­‐yl)pyridine,	  related	  to	  Scheme	  2	  
	  
Figure	  S34.	  1H	  NMR	  spectrum	  of	  methyl	  2-­‐(p-­‐tolyl)nicotinate,	  related	  to	  Scheme	  2	  
Figure	  S35.	  13C	  NMR	  spectrum	  of	  methyl	  2-­‐(p-­‐tolyl)nicotinate,	  related	  to	  Scheme	  2	  
	  
	  
Figure	  S36.	  1H	  NMR	  spectrum	  of	  3-­‐(p-­‐tolyl)pyridine,	  related	  to	  Scheme	  2	  
Figure	  S37.	  13C	  NMR	  spectrum	  of	  3-­‐(p-­‐tolyl)pyridine,	  related	  to	  Scheme	  2	  
	  
	  
Figure	  S38.	  1H	  NMR	  spectrum	  of	  3-­‐(6-­‐methoxynaphthalen-­‐2-­‐yl)pyridine,	  related	  to	  Scheme	  2	  
Figure	  S39.	  13C	  NMR	  spectrum	  of	  3-­‐(6-­‐methoxynaphthalen-­‐2-­‐yl)pyridine,	  related	  to	  Scheme	  2	  
	  
	  
Figure	  S40.	  1H	  NMR	  spectrum	  of	  5-­‐(3,4-­‐dimethoxyphenyl)-­‐1H-­‐indole,	  related	  to	  Scheme	  2	  
Figure	  S41.	  13C	  NMR	  spectrum	  of	  5-­‐(3,4-­‐dimethoxyphenyl)-­‐1H-­‐indole,	  related	  to	  Scheme	  2	  
	  
	   	  
Figure	  S42.	  1H	  NMR	  spectrum	  of	  2-­‐(4-­‐fluorophenyl)quinoline,	  related	  to	  Scheme	  2	  























Figure	  S44.	  19F	  NMR	  spectrum	  of	  2-­‐(4-­‐fluorophenyl)quinoline,	  related	  to	  Scheme	  2	  
	  
	  
Figure	  S45.	  1H	  NMR	  spectrum	  of	  2,4-­‐dimethoxy-­‐6-­‐(p-­‐tolyl)-­‐1,3,5-­‐triazine,	  related	  to	  Scheme	  2	  
Figure	  S46.	  13C	  NMR	  spectrum	  of	  2,4-­‐dimethoxy-­‐6-­‐(p-­‐tolyl)-­‐1,3,5-­‐triazine,	  related	  to	  Scheme	  2	  
	  
Figure	  S47.	  1H	  NMR	  spectrum	  of	  4-­‐(4-­‐(tert-­‐butyl)phenyl)-­‐7-­‐nitrobenzo[c][1,2,5]oxadiazole,	  
related	  to	  Scheme	  2	  
Figure	  S48.	  13C	  NMR	  spectrum	  of	  4-­‐(4-­‐(tert-­‐butyl)phenyl)-­‐7-­‐nitrobenzo[c][1,2,5]oxadiazole,	  
related	  to	  Scheme	  2	  
	  	  
	  
Figure	  S49.	  1H	  NMR	  spectrum	  of	  3',4'-­‐dimethoxy-­‐4-­‐formylbiphenyl,	  related	  to	  Scheme	  2	  
Figure	  S50.	  13C	  NMR	  spectrum	  of	  3',4'-­‐dimethoxy-­‐4-­‐formylbiphenyl,	  related	  to	  Scheme	  2	  
	  
Figure	  S51.	  1H	  NMR	  spectrum	  of	  4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxylic	  acid,	  related	  to	  
Scheme	  2	  
Figure	  S52.	  13C	  NMR	  spectrum	  of	  4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxylic	  acid,	  related	  to	  Scheme	  2	  
	   	  
	  
Figure	  S53.	  1H	  NMR	  spectrum	  of	  5-­‐(p-­‐tolyl)benzo[d][1,3]dioxole,	  related	  to	  Scheme	  2	  
Figure	  S54.	  13C	  NMR	  spectrum	  of	  5-­‐(p-­‐tolyl)benzo[d][1,3]dioxole,	  related	  to	  Scheme	  2	  
	  
Figure	  S55.	  1H	  NMR	  spectrum	  of	  2-­‐(2,4-­‐difluorophenyl)pyridine,	  related	  to	  Scheme	  2	  






Figure	  S57.	  19F	  NMR	  spectrum	  of	  2-­‐(2,4-­‐difluorophenyl)pyridine,	  related	  to	  Scheme	  2	  
	  
Figure	  S58.	  1H	  NMR	  spectrum	  of	  2,4-­‐dimethoxy-­‐6-­‐(thiophen-­‐3-­‐yl)-­‐1,3,5-­‐triazine,	  related	  to	  
Scheme	  2	  
Figure	  S59.	  13C	  NMR	  spectrum	  of	  2,4-­‐dimethoxy-­‐6-­‐(thiophen-­‐3-­‐yl)-­‐1,3,5-­‐triazine,	  related	  to	  
Scheme	  2	  
	  
Figure	  S60.	  1H	  NMR	  spectrum	  of	  3-­‐(4,6-­‐dimethoxy-­‐1,3,5-­‐triazin-­‐2-­‐yl)benzonitrile,	  related	  to	  
Scheme	  2	  
Figure	  S61.	  13C	  NMR	  spectrum	  of	  3-­‐(4,6-­‐dimethoxy-­‐1,3,5-­‐triazin-­‐2-­‐yl)benzonitrile,	  related	  to	  
Scheme	  2	  
	  
Figure	  S62.	  1H	  NMR	  spectrum	  of	  2-­‐methoxy-­‐5-­‐(p-­‐tolyl)pyridine,	  related	  to	  Scheme	  3	  
Figure	  S63.	  13C	  NMR	  spectrum	  of	  2-­‐methoxy-­‐5-­‐(p-­‐tolyl)pyridine,	  related	  to	  Scheme	  3	  
	  
	  
Figure	  S64.	  1H	  NMR	  spectrum	  of	  tert-­‐butyl	  (4-­‐(quinolin-­‐2-­‐yl)phenyl)carbamate,	  related	  to	  
Scheme	  3	  
Figure	  S65.	  13C	  NMR	  spectrum	  of	  tert-­‐butyl	  (4-­‐(quinolin-­‐2-­‐yl)phenyl)carbamate,	  related	  to	  
Scheme	  3	  
	  
Figure	  S66.	  1H	  NMR	  spectrum	  of	  4'-­‐methyl-­‐N-­‐phenyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxamide,	  related	  to	  
Scheme	  3	  
Figure	  S67.	  13C	  NMR	  spectrum	  of	  4'-­‐methyl-­‐N-­‐phenyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxamide,	  related	  to	  
Scheme	  3	  
	  
Figure	  S68.	  1H	  NMR	  spectrum	  of	  3-­‐methoxy-­‐6-­‐phenylpyridazine,	  related	  to	  Scheme	  3	  
Figure	  S69.	  13C	  NMR	  spectrum	  of	  3-­‐methoxy-­‐6-­‐phenylpyridazine,	  related	  to	  Scheme	  3	  
	  
Figure	  S70.	  1H	  NMR	  spectrum	  of	  4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxamide,	  related	  to	  Scheme	  3	  
Figure	  S71.	  13C	  NMR	  spectrum	  of	  4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxamide,	  related	  to	  Scheme	  3	  
	  
Figure	  S72.	  1H	  NMR	  spectrum	  of	  N-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxamide,	  related	  to	  Scheme	  3	  
Figure	  S73.	  13C	  NMR	  spectrum	  of	  N-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxamide,	  related	  to	  Scheme	  3	  
	  
Figure	  S74.	  1H	  NMR	  spectrum	  of	  N,N-­‐dimethyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐carboxamide,	  related	  to	  
Scheme	  3	  




Figure	  S76.	  1H	  NMR	  spectrum	  of	  N-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐sulfonamide,	  related	  to	  Scheme	  3	  
Figure	  S77.	  13C	  NMR	  spectrum	  of	  N-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐sulfonamide,	  related	  to	  Scheme	  3	  
Figure	  S78.	  1H	  NMR	  spectrum	  of	  4,7-­‐di(thiophen-­‐2-­‐yl)benzo[c][1,2,5]thiadiazole,	  related	  to	  
Scheme	  3	  




Figure	  S80.	  1H	  NMR	  spectrum	  of	  2-­‐(3,4,5-­‐trifluorophenyl)pyrazine,	  related	  to	  Scheme	  3	  












Figure	  S82.	  19F	  NMR	  spectrum	  of	  2-­‐(3,4,5-­‐trifluorophenyl)pyrazine,	  related	  to	  Scheme	  3	  
	  
Figure	  S83.	  1H	  NMR	  spectrum	  of	  2-­‐(6-­‐methoxypyridin-­‐3-­‐yl)pyrazine,	  related	  to	  Scheme	  3	  
Figure	  S84.	  13C	  NMR	  spectrum	  of	  2-­‐(6-­‐methoxypyridin-­‐3-­‐yl)pyrazine,	  related	  to	  Scheme	  3	  
	  
Figure	  S85.	  1H	  NMR	  spectrum	  of	  3-­‐(pyridin-­‐2-­‐yl)quinoline,	  related	  to	  Scheme	  3	  
Figure	  S86.	  13C	  NMR	  spectrum	  of	  3-­‐(pyridin-­‐2-­‐yl)quinoline,	  related	  to	  Scheme	  3	  
	  
Figure	  S87.	  1H	  NMR	  spectrum	  of	  4,6-­‐dimethoxy-­‐2-­‐(naphthalen-­‐1-­‐yl)pyrimidine,	  related	  to	  
Scheme	  3	  
Figure	  S88.	  13C	  NMR	  spectrum	  of	  4,6-­‐dimethoxy-­‐2-­‐(naphthalen-­‐1-­‐yl)pyrimidine,	  related	  to	  
Scheme	  3	  
	  
Figure	  S89.	  1H	  NMR	  spectrum	  of	  ethyl	  1-­‐methyl-­‐5-­‐phenyl-­‐1H-­‐indole-­‐2-­‐carboxylate,	  related	  to	  
Scheme	  3	  
Figure	  S90.	  13C	  NMR	  spectrum	  of	  ethyl	  1-­‐methyl-­‐5-­‐phenyl-­‐1H-­‐indole-­‐2-­‐carboxylate,	  related	  to	  
Scheme	  3	  
Figure	  S91.	  1H	  NMR	  spectrum	  of	  2,4-­‐di-­‐tert-­‐butyl-­‐6-­‐(5-­‐(4-­‐(trifluoromethyl)phenyl)-­‐2H-­‐
benzo[d][1,2,3]triazol-­‐2-­‐yl)phenol,	  related	  to	  Scheme	  3	  
Figure	  S92.	  13C	  NMR	  spectrum	  of	  2,4-­‐di-­‐tert-­‐butyl-­‐6-­‐(5-­‐(4-­‐(trifluoromethyl)phenyl)-­‐2H-­‐





Figure	  S93.	  19F	  NMR	  spectrum	  of	  2,4-­‐di-­‐tert-­‐butyl-­‐6-­‐(5-­‐(4-­‐(trifluoromethyl)phenyl)-­‐2H-­‐
benzo[d][1,2,3]triazol-­‐2-­‐yl)phenol,	  related	  to	  Scheme	  3	  
	  
Figure	  S94.	  1H	  NMR	  spectrum	  of	  4'-­‐methoxy-­‐3,5-­‐bis(trifluoromethyl)biphenyl,	  related	  to	  
Scheme	  3	  
Figure	  S95.	  13C	  NMR	  spectrum	  of	  4'-­‐methoxy-­‐3,5-­‐bis(trifluoromethyl)biphenyl,	  related	  to	  
Scheme	  3	  
	  
Figure	  S96.	  19F	  NMR	  spectrum	  of	  4'-­‐Methoxy-­‐3,5-­‐bis(trifluoromethyl)biphenyl,	  related	  to	  
Scheme	  3	  
	  
Figure	  S97.	  1H	  NMR	  spectrum	  of	  tert-­‐butyl	  2-­‐(4,6-­‐dimethoxypyrimidin-­‐2-­‐yl)-­‐1H-­‐pyrrole-­‐1-­‐
carboxylate,	  related	  to	  Scheme	  3	  
Figure	  S98.	  13C	  NMR	  spectrum	  of	  tert-­‐butyl	  2-­‐(4,6-­‐dimethoxypyrimidin-­‐2-­‐yl)-­‐1H-­‐pyrrole-­‐1-­‐
carboxylate,	  related	  to	  Scheme	  3	  
	  
Figure	  S99.	  1H	  NMR	  spectrum	  of	  isopropyl	  2-­‐(4-­‐([1,1'-­‐biphenyl]-­‐4-­‐carbonyl)phenoxy)-­‐2-­‐
methylpropanoate,	  related	  to	  Scheme	  4	  
Figure	  S100.	  13C	  NMR	  spectrum	  of	  isopropyl	  2-­‐(4-­‐([1,1'-­‐biphenyl]-­‐4-­‐carbonyl)phenoxy)-­‐2-­‐
methylpropanoate,	  related	  to	  Scheme	  4	  
Figure	  S101.	  1H	  NMR	  spectrum	  of	  1-­‐(4-­‐fluorophenyl)-­‐4-­‐(4-­‐hydroxy-­‐4-­‐(4'-­‐methoxy-­‐[1,1'-­‐
biphenyl]-­‐4-­‐yl)piperidin-­‐1-­‐yl)butan-­‐1-­‐one,	  related	  to	  Scheme	  4	  
Figure	  S102.	  13C	  NMR	  spectrum	  of	  1-­‐(4-­‐fluorophenyl)-­‐4-­‐(4-­‐hydroxy-­‐4-­‐(4'-­‐methoxy-­‐[1,1'-­‐























Figure	  S103.	  19F	  NMR	  spectrum	  of	  1-­‐(4-­‐fluorophenyl)-­‐4-­‐(4-­‐hydroxy-­‐4-­‐(4'-­‐methoxy-­‐[1,1'-­‐
biphenyl]-­‐4-­‐yl)piperidin-­‐1-­‐yl)butan-­‐1-­‐one,	  related	  to	  Scheme	  4	  
	  
Figure	  S104.	  1H	  NMR	  spectrum	  of	  2-­‐(5-­‐methoxy-­‐2-­‐methyl-­‐1-­‐(4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐
carbonyl)-­‐1H-­‐indol-­‐3-­‐yl)acetic	  acid,	  related	  to	  Scheme	  4	  
Figure	  S105.	  13C	  NMR	  spectrum	  of	  2-­‐(5-­‐methoxy-­‐2-­‐methyl-­‐1-­‐(4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐4-­‐
carbonyl)-­‐1H-­‐indol-­‐3-­‐yl)acetic	  acid,	  related	  to	  Scheme	  4	  
	  
Figure	  S106.	  1H	  NMR	  spectrum	  of	  N,N-­‐dimethyl-­‐3-­‐(2-­‐phenyl-­‐10H-­‐phenothiazin-­‐10-­‐yl)propan-­‐1-­‐
amine,	  related	  to	  Scheme	  4	  
Figure	  S107.	  13C	  NMR	  spectrum	  of	  N,N-­‐dimethyl-­‐3-­‐(2-­‐phenyl-­‐10H-­‐phenothiazin-­‐10-­‐yl)propan-­‐
1-­‐amine,	  related	  to	  Scheme	  4	  
	  
Figure	  S108.	  1H	  NMR	  spectrum	  of	  N-­‐(4-­‐(N-­‐(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-­‐4-­‐
methoxy-­‐4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐3-­‐carboxamide,	  related	  to	  Scheme	  4	  
Figure	  S109.	  13C	  NMR	  spectrum	  of	  N-­‐(4-­‐(N-­‐(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-­‐4-­‐
methoxy-­‐4'-­‐methyl-­‐[1,1'-­‐biphenyl]-­‐3-­‐carboxamide,	  related	  to	  Scheme	  4	  
	  
Figure	  S110.	  1H	  NMR	  spectrum	  of	  (2S,6'R)-­‐2',4,6-­‐trimethoxy-­‐6'-­‐methyl-­‐7-­‐(p-­‐tolyl)-­‐3H-­‐
spiro[benzofuran-­‐2,1'-­‐cyclohexan]-­‐2'-­‐ene-­‐3,4'-­‐dione,	  related	  to	  Scheme	  4	  
Figure	  S111.	  13C	  NMR	  spectrum	  of	  (2S,6'R)-­‐2',4,6-­‐trimethoxy-­‐6'-­‐methyl-­‐7-­‐(p-­‐tolyl)-­‐3H-­‐
spiro[benzofuran-­‐2,1'-­‐cyclohexan]-­‐2'-­‐ene-­‐3,4'-­‐dione,	  related	  to	  Scheme	  4	  
	  
Figure	  S112.	  1H	  NMR	  spectrum	  of	  N4-­‐(7-­‐(3,4-­‐dimethoxyphenyl)quinolin-­‐4-­‐yl)-­‐N1,N1-­‐
diethylpentane-­‐1,4-­‐diamine,	  related	  to	  Scheme	  4	  
Figure	  S113.	  13C	  NMR	  spectrum	  of	  N4-­‐(7-­‐(3,4-­‐dimethoxyphenyl)quinolin-­‐4-­‐yl)-­‐N1,N1-­‐
diethylpentane-­‐1,4-­‐diamine,	  related	  to	  Scheme	  4	  
Scheme S1. Comparison of IPr, SIPr and IPr*,
 
Related to Table 1. 
	  
Conditions: amide (1.0 equiv), 4-Tol-B(OH)2 (2.0 equiv), catalyst ([Pd(NHC)(µ-Cl)Cl]2, 0.05 



















H2O, toluene, 23 °C
4-Tol B(OH)2+
87 9














[Pd(IPr)(µ-Cl)Cl]2 (6), 89% yield
[Pd(SIPr)(µ-Cl)Cl]2 (11), 74% yield


























Scheme S2. Determination of Relative Reaction Rates in the Suzuki-Miyaura Cross-Coupling 
Catalyzed by [Pd-NHC], Related to Figure 2. 
 
Conditions: amide (1.0 equiv), boronic acid (2 equiv), K2CO3 (3 equiv), H2O (5.0 equiv), [(IPr)Pd(µ-Cl)Cl]2 (0.05 
mol%), for other catalysts (0.1 mol%), toluene (0.5 M).   
t/h [(IPr)Pd(cin)Cl] [(IPr)Pd(1-tBu-ind)Cl] Pd-PEPPSI-IPr [(IPr)Pd(µ-Cl)Cl]2 
0.167 0 0 0 4 
0.5 0 0 0 9 
1 1 2 1 35 
2 21 9 9 60 
4 42 25 21 89 
6 62 48 29 94 
8 76 67 36 97 
12 77 90 48 99 
20 80 92 59 100 
 
Scheme S3. Determination of Turnover number (TON) in the Suzuki-Miyaura Cross-Coupling 
Catalyzed by [(IPr)Pd(µ-Cl)Cl]2, Related to Scheme 1. 
 
 
Scheme S4. Determination of Relative Reaction Rates in the Suzuki-Miyaura Cross-Coupling 
Catalyzed by [Pd-NHC], Related to Figure 3. 
 
Conditions: ArCl (0.2 mmol), boronic acid (1.05 equiv), KOtBu (1.1 equiv) or K2CO3 (2.2 equiv), [(IPr)Pd(µ-
Cl)Cl]2 (0.5 mol%), (IPr)Pd(1-tBu-ind)Cl (1 mol%), EtOH (0.5 M), 23 °C. 
[(IPr)Pd(µ-Cl)Cl]2  [(IPr)Pd(1-tBu-ind)Cl] 
t/min 
KOtBu K2CO3 KOtBu K2CO3 
5 0 2 6 0 
10 24 28 5 4 
15 79 67 81 43 
30 83 82 83 60 
60 85 91 84 68 
 
Scheme S5. Suzuki-Miyaura Cross-Coupling of 4-Chloroanisole, Related to Figure 3. 
 
Conditions: ArCl (0.2 mmol), boronic acid (1.05 equiv), KOtBu (1.1 equiv) or K2CO3 (2.2 equiv), [(IPr)Pd(µ-
Cl)Cl]2 (x mol %), [(IPr)Pd(1-tBu-ind)Cl] (2x mol%), EtOH (0.5 M), 23 °C, 12 h; GC/
1
H NMR yields. 
Yield % 
Entry Base x 
[(IPr)Pd(µ-Cl)Cl]2 [(IPr)Pd(1-tBu-ind)Cl] 
1 0.5 93 82 
2 0.1 94 78 
3 
KOtBu 
0.05 68 65 
4 0.5 99 95 
5 0.1 99 95 
6 
K2CO3 
0.05 83 81 
 
Scheme S6. Suzuki-Miyaura Cross-Coupling of 2-Chloro-m-xylene, Related to Figure 3. 
 
Conditions: ArCl (0.2 mmol), boronic acid (1.05 equiv), KOtBu (1.1 equiv) or K2CO3 (2.2 equiv), [(IPr)Pd(µ-
Cl)Cl]2 (0.1 mol %)/[(IPr)Pd(1-tBu-ind)Cl] (0.2 mol%), EtOH (0.5 M), 23 °C, 12 h; GC/
1




1 KOtBu 76 63 
2 K2CO3 99 99 
 
Scheme S7. Suzuki-Miyaura of Aryl Chlorides at 50 ppm Pd Loading, Related to Figure 3. 
 
Conditions: ArCl (0.2 mmol), boronic acid (2 equiv), K2CO3 (3 equiv), [(IPr)Pd(µ-Cl)Cl]2  (0.0025 mol %), EtOH 
(0.5 M), 12 h. GC/
1
H NMR yields. 
Scheme S8. Plot of ln([Prod]end-[Prod]) versus time for a representative reaction involving 
catalyst, KOtBu and dvds in d4-MeOH, Related to Figure 3. 
 
 
y	  =	  -­‐0.0011x	  -­‐	  4.3747	  
R²	  =	  0.97667	  
y	  =	  -­‐0.0003x	  -­‐	  4.1695	  
R²	  =	  0.98755	  
y	  =	  -­‐0.0007x	  -­‐	  3.9845	  
























Activation	  Rate	  Pro[ile	  
(IPr)Pd(allyl)Cl	   (IPr)Pd(cin)Cl	  
Table S1. Summary of Optimization of Pd-Catalyzed Biaryl Suzuki-Miyaura Cross-Coupling, 
Related to Figure 3. 
	  









1 i-­‐PrOH	   KOt-Bu 
1.1 23 
32	  
2 EtOH	   KOt-Bu 
2.2 23 
>98	  
3 EtOH	   KOt-Bu 
1.1 23 
>98	  
4 dioxane	   KOt-Bu 
1.5 80 
76	  
5 dioxane	   Cs2CO3 1.5	  
80	   63	  
6 DME	   Cs2CO3 1.5	  
80	   50	  
7 EtOH	   K2CO3 2.2	  
23	   >98	  
8 EtOH	   K2CO3 1.5	  
23	   93	  
9 EtOH	   K2CO3 1.1	  
23	   78	  
10 MeOH	   KOt-Bu 1.1	   23	   91	  
Conditions: ArCl (1.0 equiv), catalyst (0.50 mol%), 4-Tol-B(OH)2 (1.05), base (1.1-2.2 equiv), 

















Table S2. Pd-Catalyzed Biaryl Suzuki-Miyaura Cross-Coupling with Different [Pd(NHC)(µ-




	    
 
 yield	  (%)	   yield (%) yield (%) 
X = Cl >98	   >98 >98 
X = Br 85	   87 82 
X = I <5	   <5 <5 
X = I 42b	   33b 96b 
 
 
Conditions: ArCl (1.0 equiv), catalyst (0.05 mol%), Ar-B(OH)2 (1.05), K2CO3 (2.2 equiv), EtOH 
(0.50 M), 23 °C, 12 h. 
b
60 °C. Catalysts: X = Cl: [Pd(IPr)(µ-Cl)Cl]2 (6); X = Br: [Pd(IPr)(µ-














































All DFT static calculations were performed at the GGA level with the Gaussian 09 set of 
programs (Frisch et al, 2016) using the BP86 functional of Becke and Perdew (Becke, 1988; 
Perdew, 1986; Perdew, 1986). The electronic configuration of the molecular systems was 
described with the standard split valence basis set with a polarization function of Ahlrichs and 
co-workers for H, C, B, N, O and Cl (SVP keyword in Gaussian) (Schafer et al., 1994) and Def2-
QZVPP for K (Weigend, 2006). For Pd we used the quasi-relativistic Stuttgart/Dresden effective 
core potential (Kechle et al., 1994; Leininger et al., 1996) with an associated valence basis set 
(standard SDD keywords in Gaussian 09). Geometry optimizations were performed without 
symmetry constraints, and the characterization of the stationary points was performed by 
analytical frequency calculations. These frequencies were used to calculate unscaled zero-point 
energies (ZPEs) as well as thermal corrections and entropy effects at 298 K and 1 atm by using 
the standard statistical mechanics relationships for an ideal gas. Moreover, we also included the 
D3 Grimme pairwise scheme to account for dispersion corrections in the geometry optimizations 
(Grimme et al., 2010). Energies were obtained via single-point calculations on the BP86-
optimized geometries using the M06 functional (Zhao et al., 2008). In these single-point energy 
calculations, H, C, B, N, O and Cl were described by using the Def2-TZVP basis set that 
includes polarization functions (Weigend, et al., 2005), Def2-QZVPP for K, whereas for the 
metal (Pd), the SDD basis set has been employed. On top of the M06/Def2-TZVP~sdd//BP86-
D3/SVP~sdd energies, we added the ZPEs thermal and entropy corrections obtained at the BP86-
D3/SVP~sdd level. In addition, to calculate the reported Gibbs energies, we included solvent 
effects of THF solution estimated with the polarizable continuous solvation model (PCM) as 





One-Step Synthesis of [Pd(IPr)(m-Cl)Cl]2 
In a glass vial, IPr·HCl (47.3 mg, 1 equiv.), Pd(OAc)2 (30 mg, 1.2 equiv.) and K2CO3 (55 mg, 
3.5 equiv.) were added, followed by dry toluene (0.5 mL). The reaction was heated at 80 °C 
overnight. The reaction was then filtered on celite and washed with DCM. 4M HCl in dioxane 
(0.4 mL) was added to the filtrate solution, and the mixture was stirred for 5 min. The solution 
was concentrated under vacuum. Pentane was added and the precipitate was filtered to yield 61 
mg of a dark yellow powder (81% yield). 
 
Large scale: In a glass vial, IPr·HCl (1.58 g, 1 equiv.), Pd(OAc)2 (1 g, 1.2 equiv.) and K2CO3 
(2.05 g, 4 equiv.) were added, followed by dry toluene (17 mL). The reaction was heated at 80 
°C overnight. The reaction was then filtered on celite and washed with DCM. 4M HCl in 
dioxane (10 mL) was added to the filtrate solution, and the mixture was stirred for 10 min. The 
solution was concentrated under vacuum. Pentane was added and the precipitate was filtered to 
yield 1.69 g of a dark yellow powder (81% yield). 
 
1
H NMR (400 MHz, CDCl3) δ 7.54 (t, J = 7.7 Hz, 4H), 7.34-7.29 (m, 8H), 6.98 (s, 4H), 2.86 (br. 
s, 4H), 2.60 (br. s, 4H), 1.30 (d, J = 39.9 Hz, 24H), 0.99 (d, J = 27.5 Hz, 24H). Elemental 


















List of Known Compounds/General Methods 
All starting materials reported in the manuscript have been previously described in literature and 
prepared by the method reported previously unless stated otherwise. Amides were prepared by 
standard methods. All experiments involving palladium were performed using standard Schlenk 
techniques under nitrogen or argon unless stated otherwise. All solvents were purchased at the 
highest commercial grade and used as received or after purification by passing through activated 
alumina columns or distillation from sodium/benzophenone under nitrogen. All solvents were 
deoxygenated prior to use. All other chemicals were purchased at the highest commercial grade 
and used as received. Reaction glassware was oven-dried at 140 °C for at least 24 h or flame-
dried prior to use, allowed to cool under vacuum and purged with argon (three cycles). All 
products were identified using 
1
H NMR analysis and comparison with authentic samples. GC 
and/or GC/MS analysis was used for volatile products. All yields refer to yields determined by 
1
H NMR and/or GC or GC/MS using an internal standard (optimization) and isolated yields 
(preparative runs) unless stated otherwise.
1
H NMR and 
13
C NMR spectra were recorded in 
CDCl3 or DMSO on Bruker spectrometers at 500 (
1
H NMR), 125 (
13
C NMR) and 471 (
19
F 
NMR) MHz. All shifts are reported in parts per million (ppm) relative to residual CHCl3 peak 
(7.26 and 77.16 ppm, 
1
H NMR and 
13
C NMR, respectively). All coupling constants (J) are 
reported in hertz (Hz). Abbreviations are: s, singlet; d, doublet; t, triplet; q, quartet; brs, broad 
singlet. GC-MS chromatography was performed using Agilent HP6890 GC System and Agilent 
5973A inert XL EI/CI MSD using helium as the carrier gas at a flow rate of 1 mL/min and an 
initial oven temperature of 50 °C. The injector temperature was 250 °C. The detector 
temperature was 250 °C. For runs with the initial oven temperature of 50 °C, temperature was 
increased with a 10 °C/min ramp after 50 °C hold for 3 min to a final temperature of 220 °C, 
then hold at 220 °C for 15 min (splitless mode of injection, total run time 22.0 min). High-
resolution mass spectra were measured on a 7T Bruker Daltonics FT-MS instrument. All flash 
chromatography was performed using silica gel, 60 A, 300 mesh. TLC analysis was carried out 
on glass plates coated with silica gel 60 F254, 0.2 mm thickness. The plates were visualized 
using a 254 nm ultraviolet lamp or aqueous potassium permanganate. 
1
H NMR and 
13
C NMR 




C NMR and 
HRMS data are given for all new compounds. All products have been previously reported unless 
stated otherwise. 
Experimental Procedures and Characterization Data 
General Procedure for the Synthesis of Starting Materials. All amides used in this study have 
been previously reported and prepared by reported methods (Zhou et al., 2019; Lei et al.; 2017; 
Liu et al., 2018; Monguchi et al., 2012; Lipshutz et al., 2008). Starting materials were 
synthesized according to general methods reported in the literature (Al-Huniti et al., 2018; 
Ackermann et al., 2011; Patel et al., 2012; Sun et al, 2016; Wang et al., 2017; Zhang et al., 
2017). Catalysts [(IPr)Pd(µ-Br)Br]2 and [(IPr)Pd(µ-I)I]2 were prepared according to literature 
(Deska et al., 2010; Flahaut et al., 2009). 
1
H NMR and 
13
C NMR data are given for all starting 
materials in the section below for characterization purposes. 
tert-­Butyl	   benzoyl(phenyl)carbamate.	  White	   solid.	   1H	  NMR	   (500	  MHz,	  
CDCl3)	  δ	  7.76	  (d,	  J	  =	  7.1	  Hz,	  2	  H),	  7.55	  (t,	  J	  =	  7.4	  Hz,	  1	  H),	  7.49-­‐7.43	  (m,	  4	  H),	  
7.37	  (t,	  J	  =	  7.4	  Hz,	  1	  H),	  7.30	  (d,	  J	  =	  7.4	  Hz,	  2	  H),	  1.26	  (s,	  9	  H).	  13C	  NMR	  (125	  
MHz,	   CDCl3)	   δ	   172.78,	   153.30,	   139.10,	   136.98,	   131.72,	   129.21,	   128.28,	   128.14,	   127.96,	  
127.80,	  83.50,	  27.49.	  (Zhou	  et	  al.,	  2019)	  
	  
tert-­Butyl	   (4-­methoxybenzoyl)(phenyl)carbamate.	   White	   solid.	  
1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.77	  (d,	  J	  =	  7.6	  Hz,	  2	  H),	  7.43	  (t,	  J	  =	  7.2	  
Hz,	  2	  H),	  7.33	  (t,	  J	  =	  7.3	  Hz,	  1	  H),	  7.28	  (d,	  J	  =	  7.9	  Hz,	  2	  H),	  6.95	  (d,	  J	  =	  
7.7	  Hz,	  2H),	  3.88	  (s,	  3	  H),	  1.32	  (s,	  9	  H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  172.07,	  162.78,	  153.53,	  
139.48,	   130.86,	   129.12,	   128.72,	   127.75,	   127.48,	   113.56,	   83.10,	   55.49,	   27.65.	   (Zhou	   et	   al.,	  
2019)	  
	  
	  tert-­Butyl	   phenyl((4-­(methoxycarbonyl)benzoyl)carbamate.	  
White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.14	  (d,	  J	  =	  8.1	  Hz,	  2	  H),	  
7.78	  (d,	  J	  =	  8.1	  Hz,	  2	  H),	  7.46	  (t,	  J	  =	  7.6	  Hz,	  2	  H),	  7.38	  (t,	  J	  =	  7.3	  Hz,	  1	  
H),	  7.28	  (d,	  J	  =	  7.8	  Hz,	  2	  H),	  3.97	  (s,	  3	  H),	  1.26	  (s,	  9	  H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  171.83,	  
166.21,	   152.93,	   141.01,	   138.62,	   132.53,	   129.52,	   129.27,	   128.07,	   127.99,	   127.78,	   84.01,	  
52.42,	  27.51.	  (Zhou	  et	  al.,	  2019)	  
 tert-Butyl decanoyl(phenyl)carbamate. White solid. 
1
H NMR 
(500 MHz, CDCl3) δ 7.41(t, J=7.2 Hz, 2H), 7.34(t, J=7.3 
Hz,1H), 7.09(d, J=7.7 Hz,2H), 2.92 (t, J = 7.4 Hz, 2 H), 1.70 (p, 
J = 7.3, 6.8 Hz, 2 H), 1.40 (s, 9 H), 1.29 (s, 12 H), 0.90 (t, J = 
6.4 Hz, 3 H). 
13
C NMR (125 MHz, CDCl3) δ 176.0, 152.3, 139.2, 128.9, 128.2, 127.7, 82.9, 38.0, 
31.9, 29.5, 29.3, 29.2, 27.8, 25.0, 22.7, 14.1. (Zhou et al., 2019) 
4-Chlorobenzamide. White solid.
 1
H NMR (500 MHz, CDCl
3
) δ 7.76 (d, J 
= 8.6 Hz, 2H), 7.43 (d, J = 8.5 Hz, 2H), 5.92 (brs, 2H). 
13
C NMR (125 MHz, 
CDCl
3
) δ 168.32, 138.51, 131.84, 129.07, 128.94. (Al-Huniti et al., 2018) 
4-Chloro-N-methylbenzamide. White solid.
 1
H NMR (500 MHz, CDCl
3
) 
δ 7.70 (d, J = 8.1 Hz, 2H), 7.39 (d, J = 8.5 Hz, 2H), 6.24 (brs, 1H), 3.00 
(d, J = 4.9 Hz, 3H). 
13
C NMR (125 MHz, CDCl
3
) δ 167.38, 137.75, 
133.07, 128.95, 128.42, 27.06. (Ackermann et al., 2011) 
4-­Chloro-­N,N-­dimethylbenzamide.	   White	   solid.	   1H	   NMR	   (500	   MHz,	  
CDCl3)	   δ	   7.36	   (s,	   4H),	   3.09	   (s,	   3H),	   2.96	   (s,	   3H).	  
13C	  NMR	   (125	  MHz,	  
CDCl3)	  δ	  170.68,	  135.70,	  134.67,	  131.44,	  128.72,	  39.68,	  35.56.	  (Patel	  et	  
al.,	  2012).	  
4-­Chloro-­N-­phenylbenzamide.	   White	   solid.	   1H	   NMR	   (500	   MHz,	  
DMSO-­‐d6)	  δ	  10.31	  (s,	  1H),	  7.99	  (d,	  J	  =	  8.5	  Hz,	  2H),	  7.77	  (d,	   J	  =	  7.6	  Hz,	  
2H),	  7.61	  (d,	  J	  =	  8.5	  Hz,	  2H),	  7.36	  (t,	  J	  =	  7.9	  Hz,	  2H),	  7.11	  (t,	  J	  =	  7.3	  Hz,	  
1H).	  13C	  NMR	  (126	  MHz,	  DMSO-­‐d6)	  δ	  164.39,	  138.94,	  136.35,	  133.63,	  
129.59,	  128.59,	  128.42,	  123.79,	  120.40.	  (Sun	  et	  al.,	  2016).	  
4-Chloro-N-methylbenzenesulfonamide. White solid. 
1
H NMR (500 
MHz, CDCl3) δ 7.80 (d, J = 8.7 Hz, 2H), 7.50 (d, J = 8.6 Hz, 2H), 4.51 
(d, J = 5.7 Hz, 1H), 2.67 (d, J = 5.4 Hz, 3H). 
13
C NMR (125 MHz, CDCl3) δ 139.42, 137.55, 
129.58, 128.83, 29.45. (Wang et al., 2017) 
  
 Ethyl 5-chloro-1-methyl-1H-indole-2-carboxylate. White solid.
 1
H 
NMR (500 MHz, CDCl3) δ 7.65 – 7.60 (m, 1H), 7.30 – 7.28 (m, 2H), 7.21 
(s, 1H), 4.38 (q, J = 7.1 Hz, 2H), 4.06 (s, 4H), 1.41 (t, J = 7.1 Hz, 3H). 
13
C 
NMR (125 MHz, CDCl3) δ 162.05, 138.03, 129.30, 126.77, 126.30, 125.45, 121.72, 111.50, 
109.41, 60.88, 31.96, 14.49. (Zhang et al., 2017) 
 [(IPr)Pd(µ-Br)Br]2. Brown solid. 
1
H NMR (500 MHz, 
CDCl3) δ 7.54 (t, J = 7.7 Hz, 4H), 7.34 (d, J = 7.7 Hz, 4H), 
7.28 – 7.26 (m, 4H), 7.01 (s, 4H), 3.11 – 2.95 (m, 4H), 2.71 – 
2.58 (m, 4H), 1.41 (d, J = 6.5 Hz, 12H), 1.23 (d, J = 7.8 Hz, 
12H), 1.05 (d, J = 6.8 Hz, 12H), 0.94 (d, J = 6.8 Hz, 12H). 
13
C 
NMR (126 MHz, CDCl3) δ 153.13, 146.72, 146.31, 134.79, 130.49, 125.59, 124.52, 124.41, 
28.96, 26.55, 26.52, 23.67, 23.62. (Deska et al., 2010) 
 [(IPr)Pd(µ-I)I]2. Red solid. 
1
H NMR (500 MHz, CDCl3) δ 
7.51 (t, J = 7.8 Hz, 4H), 7.34 (d, J = 7.4 Hz, 4H), 7.27 – 7.22 
(m, 4H), 7.09 (s, 4H), 3.34 – 3.24 (m, 4H), 2.89 – 2.62 (m, 
4H), 1.47 (d, J = 6.6 Hz, 12H), 1.25 (d, J = 6.7 Hz, 12H), 1.08 
(d, J = 6.9 Hz, 12H), 0.94 (d, J = 6.8 Hz, 12H). 
13
C NMR (126 
MHz, CDCl3) δ 165.65, 146.53, 146.10, 135.53, 130.42, 125.54, 124.83, 124.42, 29.23, 26.67, 
26.63, 24.19, 24.14. (Flahaut et al., 2009) 
General Procedure for the Suzuki-Miyaura Cross-Coupling of Amides. An oven-dried vial 
equipped with a stir bar was charged with an amide substrate (neat, 1.0 equiv), potassium 
carbonate (typically, 3.0 equiv), boronic acid (typically, 2.0 equiv), Pd-NHC catalyst (typically, 
0.5 mol%), water (typically, 5 equiv) placed under a positive pressure of argon, and subjected to 
three evacuation/backfilling cycles under high vacuum. Toluene (typically, 0.5 M) was added 
with vigorous stirring at room temperature, the reaction mixture was placed in a preheated oil 
bath and stirred for the indicated time. After the indicated time, the reaction mixture was cooled 
down to room temperature, diluted with CH2Cl2 (10 mL), filtered, and concentrated. A sample 
was analyzed by 
1
H NMR (CDCl3, 500 MHz) and GC-MS to obtain conversion, selectivity and 
yield using internal standard and comparison with authentic samples. Purification by 
chromatography on silica gel (EtOAc/hexanes) afforded the tile product.  
Phenyl(p-­tolyl)methanone	  (Scheme	  1,	  9a)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	  of	   tert-­‐butyl	   benzoyl(phenyl)carbamate	  
(0.20	  mmol),	   4-­‐methylphenylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv),	   H2O	   (5	   equiv)	   and	  
[(IPr)Pd(µ-­‐Cl)Cl]2	   (0.05	  mol%)	  in	  toluene	  (0.5	  M)	  for	  16	  h	  at	  room	  temperature,	  afforded	  
after	   work-­‐up	   and	   chromatography	   the	   title	   compound	   in	   89	  %	   yield	   (34.9	   mg).	   White	  
solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.79	  (d,	  J	  =	  6.9	  Hz,	  2H),	  7.73	  (d,	  J	  =	  8.2	  Hz,	  2H),	  7.58	  (t,	  J	  =	  
7.4	  Hz,	  1H),	  7.47	  (t,	  J	  =	  7.7	  Hz,	  2H),	  7.28	  (d,	  J	  =	  7.9	  Hz,	  2H),	  2.44	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  
CDCl3)	   δ	   196.64,	   143.37,	   138.09,	   135.01,	   132.29,	   130.44,	   130.06,	   129.10,	   128.34,	   21.80.	  
NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Zhou	  et	  al.,	  2019).	  
(4-­Methoxyphenyl)(phenyl)methanone	  (Scheme	  1,	  9b)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	  of	   tert-­‐butyl	   benzoyl(phenyl)carbamate	  
(0.20	  mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv),	  H2O	  (5	  equiv)	  and	  [(IPr)Pd(µ-­‐
Cl)Cl]2	  (0.25	  mol%)	  in	  toluene	  (1	  M)	  for	  12	  h	  at	  room	  temperature,	  afforded	  after	  work-­‐up	  
and	  chromatography	  the	  title	  compound	  in	  98	  %	  yield	  (41.6	  mg).	  White	  solid.	  1H	  NMR	  (500	  
MHz,	  CDCl3)	  δ	  7.83	  (d,	  J	  =	  8.8	  Hz,	  2H),	  7.76	  (d,	  J	  =	  6.8	  Hz,	  2H),	  7.57	  (t,	  J	  =	  7.4	  Hz,	  1H),	  7.47	  (t,	  
J	  =	  7.7	  Hz,	  2H),	  6.97	  (d,	  J	  =	  8.9	  Hz,	  2H),	  3.89	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  195.71,	  
163.36,	  138.43,	  132.70,	  132.03,	  130.31,	  129.87,	  128.33,	  113.69,	  55.65.	  NMR	  spectroscopic	  
data	  agreed	  with	  literature	  values	  (Zhou	  et	  al.,	  2019).	  
Phenyl(4-­(trifluoromethyl)phenyl)methanone	  (Scheme	  1,	  9c)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	  of	   tert-­‐butyl	   benzoyl(phenyl)carbamate	  
(0.20	   mmol),	   (4-­‐trifluoromethyl)phenylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv),	   H2O	   (5	  
equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  toluene	  (1	  M)	  for	  12	  h	  at	  room	  temperature,	  
afforded	  after	  work-­‐up	  and	  chromatography	  the	  title	  compound	  in	  82	  %	  yield	  (41.1	  mg).	  1H	  
NMR	  (500	  MHz,	  CDCl3)	  δ	  7.89	  (d,	  J	  =	  8.0	  Hz,	  2H),	  7.81	  (d,	  J	  =	  6.9	  Hz,	  2H),	  7.76	  (d,	  J	  =	  8.1	  Hz,	  
2H),	  7.63	  (t,	   J	  =	  7.5	  Hz,	  1H),	  7.51	  (t,	   J	  =	  7.8	  Hz,	  2H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  195.65,	  
140.86,	  136.86,	  133.85	  (q,	  JF	  =	  32.7	  Hz),	  133.22,	  130.27,	  130.24,	  128.66,	  125.48	  (q,	  JF	  =	  3.6	  
Hz),	  123.81	  (q,	  JF	  =	  272.7	  Hz).	  19F	  NMR	  (471	  MHz,	  CDCl3)	  δ	  -­‐63.01.	  NMR	  spectroscopic	  data	  
agreed	  with	  literature	  values	  (Zhou	  et	  al.,	  2019).	  
1-­Phenyldecan-­1-­one	  (Scheme	  1,	  9d)	  
	  
According	  to	  the	  general	  procedure,	  the	  reaction	  of	  tert-­‐butyl	  decanoyl(phenyl)carbamate	  
(0.20	  mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv),	  H2O	  (5	  equiv)	  and	  [(IPr)Pd(µ-­‐
Cl)Cl]2	  	  (0.5	  mol%)	  in	  toluene	  (1	  M)	  for	  12	  h	  at	  room	  temperature,	  afforded	  after	  work-­‐up	  
and	  chromatography	  the	  title	  compound	  in	  91	  %	  yield	  (42.3	  mg).	  White	  solid.	  1H	  NMR	  (500	  
MHz,	  CDCl3)	  δ	  7.96	  (d,	  J	  =	  7.3	  Hz,	  2H),	  7.55	  (t,	  J	  =	  7.4	  Hz,	  1H),	  7.46	  (t,	  J	  =	  7.6	  Hz,	  2H),	  2.96	  (t,	  J	  
=	  7.4	  Hz,	  2H),	  1.73	  (p,	  J	  =	  7.4	  Hz,	  2H),	  1.41	  –	  1.25	  (m,	  12H),	  0.88	  (t,	  J	  =	  6.8	  Hz,	  3H).	  13C	  NMR	  
(125	   MHz,	   CDCl3)	   δ	   200.77,	   137.25,	   132.98,	   128.68,	   128.20,	   38.79,	   32.03,	   29.64,	   29.62,	  
29.54,	  29.43,	  24.55,	  22.82,	  14.26.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Lei	  
et	  al.,	  2017).	  
(4-­Methoxyphenyl)(phenyl)methanone	  (Scheme	  1,	  9b')	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   tert-­‐butyl	   (4-­‐
methoxybenzoyl)(phenyl)carbamate	  (0.20	  mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	   (3	  
equiv),	  H2O	  (5	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.5	  mol%)	  in	  toluene	  (0.5	  M)	  for	  12	  h	  at	  room	  
temperature,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  title	  compound	  in	  93	  %	  yield	  
(39.5	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.83	  (d,	  J	  =	  8.8	  Hz,	  2H),	  7.76	  (d,	  J	  =	  6.8	  
Hz,	  2H),	  7.57	  (t,	  J	  =	  7.4	  Hz,	  1H),	  7.47	  (t,	  J	  =	  7.7	  Hz,	  2H),	  6.97	  (d,	  J	  =	  8.9	  Hz,	  2H),	  3.89	  (s,	  3H).	  
13C	   NMR	   (125	   MHz,	   CDCl3)	   δ	   195.71,	   163.36,	   138.43,	   132.70,	   132.03,	   130.31,	   129.87,	  
128.33,	  113.69,	  55.65.	  NMR	  spectroscopic	  data	  agreed	  with	   literature	  values	   (Zhou	  et	  al.,	  
2019).	  
Methyl	  4-­benzoylbenzoate	  (Scheme	  1,	  9e)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   tert-­‐butyl	   phenyl((4-­‐
(methoxycarbonyl)benzoyl)carbamate	  (0.20	  mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  
equiv),	  H2O	  (5	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.5	  mol%)	  in	  toluene	  (1	  M)	  for	  12	  h	  at	  room	  
temperature,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  title	  compound	  in	  99	  %	  yield	  
(47.5	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.15	  (d,	  J	  =	  8.4	  Hz,	  2H),	  7.84	  (d,	  J	  =	  8.4	  
Hz,	  2H),	  7.81	  (d,	  J	  =	  6.9	  Hz,	  2H),	  7.62	  (t,	  J	  =	  7.5	  Hz,	  1H),	  7.50	  (t,	  J	  =	  7.8	  Hz,	  2H),	  3.97	  (s,	  3H).	  
13C	   NMR	   (125	   MHz,	   CDCl3)	   δ	   196.19,	   166.47,	   141.47,	   137.10,	   133.37,	   133.09,	   130.25,	  
129.92,	  129.65,	  128.61,	  52.63.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Zhou	  
et	  al.,	  2019).	  
Phenyl(o-­tolyl)methanone	  (Scheme	  1,	  9d)	  
 
According to the general procedure, the reaction of tert-butyl benzoyl(phenyl)carbamate (0.20 
mmol), 2-methylphenylboronic acid (2 equiv), K2CO3 (3 equiv), H2O (5 equiv) and [(IPr
*
)Pd(µ-
Cl)Cl]2 (0.25 mol%) in toluene (1 M) for 12 h at room temperature, afforded after work-up and 
chromatography the title compound in 83 % yield (32.6 mg). 
1
H NMR (500 MHz, CDCl3) δ 7.80 
(d, J = 6.8 Hz, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.7 Hz, 2H), 7.39 (t, J = 7.4 Hz, 1H), 
7.34 – 7.28 (m, 2H), 7.24 (d, J = 7.5 Hz, 1H), 2.33 (s, 3H).	   13C NMR (125 MHz, CDCl3) δ 
198.78, 138.78, 137.90, 136.89, 133.26, 131.13, 130.37, 130.27, 128.66, 128.60, 125.33, 20.13. 
NMR spectroscopic data agreed with literature values (Zhou et al., 2019).	  
Determination	  of	  Kinetic	  Profiles	  Amides	  
General	  Procedure.	  An	  oven-­‐dried	  vial	  equipped	  with	  a	  stir	  bar	  was	  charged	  with	  tert-­‐butyl	  
benzoyl(phenyl)carbamate	  (neat,	  0.20	  mmol,	  1.0	  equiv),	  potassium	  carbonate	  (3.0	  equiv),	  
4-­‐Tolylboronic	   acid	   (2.0	   equiv),	   water	   (5.0	   equiv),	   NHC-­‐Pd	   (0.05	   mol%	   for	   [(IPr)Pd(µ-­‐
Cl)Cl]2	   ,	   0.1	   mol%	   for	   other	   catalysts),	   placed	   under	   a	   positive	   pressure	   of	   argon,	   and	  
subjected	  to	  three	  evacuation/backfilling	  cycles	  under	  high	  vacuum.	  Toluene	  (0.5	  M)	  was	  
added	  with	  vigorous	  stirring	  and	  the	  reaction	  mixture	  was	  stirred	  at	  23	  °C	  for	  the	  indicated	  
time.	   After	   the	   indicated	   time,	   the	   reaction	   mixture	   was	   diluted	   with	   CH2Cl2	   (10	   mL),	  
filtered,	  and	  concentrated.	  The	  sample	  was	  analyzed	  by	  1H	  NMR	  (CDCl3,	  500	  MHz)	  and/or	  
GC-­‐	  MS	  to	  obtain	  conversion,	  selectivity	  and	  yield	  using	  internal	  standard	  and	  comparison	  
with	  authentic	  samples.	  	  
Determination of Turnover Number	  
General	  Procedure.	  An	  oven-­‐dried	  vial	  equipped	  with	  a	  stir	  bar	  was	  charged	  with	  an	  amide	  
substrate	   (neat,	   1.0	   equiv),	   potassium	   carbonate	   (3.0	   equiv),	   boronic	   acid	   (2.0	   equiv)	  
placed	   under	   a	   positive	   pressure	   of	   argon,	   and	   subjected	   to	   three	   evacuation/backfilling	  
cycles	   under	   high	   vacuum.	   A	   stock	   solution	   of	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.0025	   mol	   %)	   in	   2-­‐
Methyltetrahydrofuran	  (0.5	  M)	  was	  added	  with	  vigorous	  stirring	  at	  room	  temperature,	  the	  
reaction	  mixture	  was	  placed	   in	   a	   preheated	   oil	   bath	   at	   100	   °C	   or	   120	   °C	   and	   stirred	   the	  
same	  temperature	  for	  16	  h.	  After	  the	  indicated	  time,	  the	  reaction	  mixture	  was	  cooled	  down	  
to	  room	  temperature,	  diluted	  with	  CH2Cl2	  (10	  mL),	  filtered,	  and	  concentrated.	  The	  sample	  
was	  analyzed	  by	  1	  H	  NMR	  (CDCl3,	  500	  MHz)	  and/or	  GC-­‐MS	  to	  obtain	  conversion,	  selectivity	  
and	  yield	  using	  internal	  standard	  and	  comparison	  with	  authentic	  samples.	  	  
General	  Procedure	  for	  the	  Suzuki-­Miyaura	  Cross-­Coupling	  of	  Aryl	  Chlorides.	  An	  oven-­‐
dried	  vial	  equipped	  with	  a	  stir	  bar	  was	  charged	  with	  an	  aryl	  chloride	  or	  bromide	  (neat,	  1.0	  
equiv),	  potassium	  carbonate	  (typically,	  3.0	  equiv),	  boronic	  acid	  (typically,	  2.0	  equiv)	  placed	  
under	   a	   positive	   pressure	   of	   argon,	   and	   subjected	   to	   three	   evacuation/backfilling	   cycles	  
under	  high	  vacuum.	  Ethanol	   (typically,	  0.5	  M)	  containing	  Pd-­‐NHC	  catalyst	   (typically,	  0.25	  
mol	  %)	  was	   added	  with	   vigorous	   stirring	   at	   indicated	   temperature,	   the	   reaction	  mixture	  
was	  placed	   in	  a	  preheated	  oil	  bath	  and	  stirred	   for	   the	   indicated	   time.	  After	   the	   indicated	  
time,	  the	  reaction	  mixture	  was	  cooled	  down	  to	  room	  temperature,	  diluted	  with	  CH2Cl2	  (10	  
mL),	  filtered,	  and	  concentrated.	  A	  sample	  was	  analyzed	  by	  1H	  NMR	  (CDCl3,	  500	  MHz)	  and	  
GC-­‐MS	  to	  obtain	  conversion,	  selectivity	  and	  yield	  using	  internal	  standard	  and	  comparison	  
with	   authentic	   samples.	   Purification	   by	   chromatography	   on	   silica	   gel	   (EtOAc/hexanes)	  
afforded	  the	  title	  product.	  	  
Determination	  of	  Kinetic	  Profiles	  Aryl	  Chlorides	  
General	   Procedure.	   An	   oven-­‐dried	   vial	   equipped	   with	   a	   stir	   bar	   was	   charged	   with	   4-­‐
chlorotoluene	   (neat,	   0.20	   mmol,	   1.0	   equiv),	   KOtBu	   (1.1	   equiv)	   or	   K2CO3	   (2.2	   equiv),	  
phenylboronic	  acid	  (1.05	  equiv)	  placed	  under	  a	  positive	  pressure	  of	  argon,	  and	  subjected	  to	  
three	   evacuation/backfilling	   cycles	  under	  high	  vacuum.	  EtOH	   (0.5	  M)	   containing	  NHC-­‐Pd	  
(0.5	   mol%	   for	   [(IPr)Pd(µ-­‐Cl)Cl]2,	   1	   mol%	   for	   (IPr)Pd(1-­‐tBu-­‐ind)Cl)	   was	   added	   with	  
vigorous	  stirring	  and	  the	  reaction	  mixture	  was	  stirred	  at	  23	  °C	  for	  the	  indicated	  time.	  After	  
the	   indicated	   time,	   the	   reaction	   mixture	   was	   diluted	   with	   CH2Cl2	   (10	   mL),	   filtered,	   and	  
concentrated.	  The	   sample	  was	  analyzed	  by	   1	  H	  NMR	  (CDCl3,	   500	  MHz)	  and/or	  GC-­‐	  MS	   to	  
obtain	   conversion,	   selectivity	   and	   yield	   using	   internal	   standard	   and	   comparison	   with	  
authentic	  samples.	  	  
[(IPr)Pd(µ-­Cl)Cl]2	  Catalyzed	  Suzuki-­Miyaura	  Cross-­Coupling	  at	  Low	  Palladium	  
Loading	  
General	  Procedure.	  An	  oven-­‐dried	  vial	   equipped	  with	  a	   stir	  bar	  was	  charged	  with	  an	  aryl	  
chloride	  or	  bromide	  (neat,	  1.0	  equiv),	  potassium	  carbonate	   (typically,	  3.0	  equiv),	  boronic	  
acid	  (typically,	  2.0	  equiv)	  placed	  under	  a	  positive	  pressure	  of	  argon,	  and	  subjected	  to	  three	  
evacuation/backfilling	   cycles	   under	   high	   vacuum.	   Ethanol	   (typically,	   0.5	   M)	   containing	  
[(IPr)Pd(µ-­‐Cl)Cl]2	  	  (typically,	  0.0025	  mol	  %)	  was	  added	  with	  vigorous	  stirring	  at	  indicated	  
temperature,	   the	   reaction	  mixture	  was	  placed	   in	  a	  preheated	  oil	  bath	  and	   stirred	   for	   the	  
indicated	   time.	   After	   the	   indicated	   time,	   the	   reaction	  mixture	  was	   cooled	   down	   to	   room	  
temperature,	   diluted	   with	   CH2Cl2	   (10	   mL),	   filtered,	   and	   concentrated.	   A	   sample	   was	  
analyzed	   by	   1H	  NMR	   (CDCl3,	   500	  MHz)	   and	   GC-­‐MS	   to	   obtain	   conversion,	   selectivity	   and	  
yield	  using	  internal	  standard	  and	  comparison	  with	  authentic	  samples.	  	  
Experiments	  on	  Activation	  of	  Pd(II)	  to	  Pd(0)	  
Rates	   of	   Activation	   of	   [(IPr)Pd(allyl)Cl],	   [(IPr)Pd(cin)Cl]	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   	   in	   the	  
presence	  of	  dvds	  were	  determined	  according	  to	  the	  previous	  report	  (Melvin	  et	  al.,	  2015).	  	  
General	  Procedure.	  	  KOtBu	  (9.8	  mg,	  0.087	  mmol)	  was	  dissolved	  in	  300	  μL	  of	  d4-­‐MeOH	  along	  
with	   100	   μL	   of	   a	   0.87	  M	   solution	   of	   dvds	   in	   d4-­‐MeOH.	   [(IPr)Pd(allyl)Cl]	   (5.0	  mg,	   0.0087	  
mmol),	   [(IPr)Pd(cin)Cl]	   (5.6	   mg,	   0.0087	   mmol),	   or	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (4.9	   mg,	   0.00435	  
mmol)	  was	  dissolved	  in	  100	  μL	  of	  d4-­‐MeOH.	  These	  solutions	  were	  combined	  in	  a	  J.	  Young	  
NMR	   tube	   at	   −78	   °C.	   The	   reaction	  mixture	   was	   degassed	   on	   a	   Schlenk	   line,	   after	   which	  
dinitrogen	  was	  introduced	  into	  the	  NMR	  tube.	  An	  array	  of	  1	  H	  NMR	  spectra	  was	  taken	  at	  25	  
°C	   over	   the	   course	   of	   3	   h.	   During	   this	   time,	   the	   growth	   of	   the	   methyl	   protons	   of	   the	  
(IPr)Pd(dvds)	  product	  were	  monitored.	  	  
4-­Methylbiphenyl	  (Table	  S2)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chlorotoluene	   (0.20	   mmol),	  
phenylboronic	  acid	  (1.05	  equiv),	  K2CO3	  (2.2	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	   	  (0.05	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   23	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  98	  %	  yield	  (33.1	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.58	  (d,	  J	  =	  7.9	  
Hz,	  2H),	  7.50	  (d,	  J	  =	  7.8	  Hz,	  2H),	  7.43	  (t,	  J	  =	  7.7	  Hz,	  2H),	  7.34	  (t,	  1H),	  7.26	  (d,	  J	  =	  7.7	  Hz,	  3H),	  
2.40	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  141.30,	  138.50,	  137.16,	  129.62,	  128.85,	  127.14,	  
127.12,	  21.25.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Liu	  et	  al.,	  2018).	  
4-­Methoxybiphenyl	  (Table	  S2)	  
	  	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chloroanisole	   (0.20	   mmol),	  
phenylboronic	  acid	  (1.05	  equiv),	  K2CO3	  (2.2	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	   	  (0.05	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   23	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  98	  %	  yield	  (36.2	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.59	  –	  7.49	  (m,	  
4H),	  7.42	  (t,	  J	  =	  7.8	  Hz,	  2H),	  7.31	  (t,	  J	  =	  7.3	  Hz,	  1H),	  6.98	  (d,	  J	  =	  8.7	  Hz,	  2H),	  3.86	  (s,	  3H).	  13C	  
NMR	  (125	  MHz,	  CDCl3)	  δ	  159.39,	  141.08,	  134.04,	  128.96,	  128.40,	  126.98,	  126.90,	  114.45,	  
55.60.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Monguchi	  et	  al.,	  2012).	  
4'-­Methoxy-­2,6-­dimethylbiphenyl	  (Table	  S2)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2-­‐chloro-­‐m-­‐xylene	   (0.20	  mmol),	   (4-­‐
methoxyl)phenylboronic	  acid	  (1.05	  equiv),	  K2CO3	  (2.2	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	   	  (0.05	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  23	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  98	  %	  yield	  (41.7	  mg).	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.18	  –	  7.13	  (m,	  1H),	  
7.10	  (d,	  J	  =	  8.0	  Hz,	  2H),	  7.06	  (d,	  J	  =	  8.7	  Hz,	  2H),	  6.97	  (d,	  J	  =	  8.6	  Hz,	  2H),	  3.86	  (s,	  3H),	  2.04	  (s,	  
6H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  158.40,	  141.66,	  136.67,	  133.47,	  130.21,	  127.38,	  127.02,	  
113.95,	  55.37,	  21.05.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Lipshutz	  et	  al,	  
2008).	  
4-­Cyano-­4'-­methylbiphenyl	  (Scheme	  2) 
	  
According	   to	   the	   general	  procedure,	   the	   reaction	  of	  4-­‐chlorobenzonitrile	   (0.20	  mmol),	   4-­‐
methylphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   23	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  97	  %	  yield	  (37.5	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.74	  –	  7.62	  (m,	  
4H),	  7.50	  (d,	  J	  =	  8.2	  Hz,	  2H),	  7.29	  (d,	  J	  =	  7.9	  Hz,	  2H),	  2.42	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  
δ	   145.71,	   138.87,	   136.37,	   132.67,	   129.95,	   127.57,	   127.17,	   119.16,	   110.65,	   21.31.	   NMR	  
spectroscopic	  data	  agreed	  with	  literature	  values	  (Liu	  et	  al.,	  2011).	  
4-­Hydroxy-­4'-­methylbiphenyl	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 4-bromophenol (0.20 mmol), 4-
methylphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 95 % yield (35.1 mg). White solid. 
1
H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.4 Hz, 2H), 
7.44 (d, J = 7.9 Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 4.80 (s, 1H), 2.38 (s, 
3H). 
13
C NMR (125 MHz, CDCl3) δ 154.97, 138.03, 136.56, 134.14, 129.58, 128.33, 126.71, 
115.72, 21.20. NMR spectroscopic data agreed with literature values (Edwards et al., 2014).
 
4-­Amino-­4'-­methylbiphenyl	  (Scheme	  2)	  
 
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chloroaniline	   (0.20	   mmol),	   4-­‐
methylphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  78	  %	  yield	  (28.6	  mg).	  Yellow	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.43	  (d,	  J	  =	  8.2	  
Hz,	  2H),	  7.40	  (d,	  J	  =	  8.5	  Hz,	  2H),	  7.21	  (d,	  J	  =	  7.9	  Hz,	  2H),	  6.75	  (d,	  J	  =	  8.5	  Hz,	  2H),	  3.70	  (s,	  2H),	  
2.37	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  145.70,	  138.46,	  136.04,	  131.76,	  129.50,	  127.96,	  
126.41,	  115.53,	  21.18.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Kamio	  et	  al.,	  
2019).	  
2-­Amino-­4'-­methylbiphenyl	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 2-chloroaniline (0.20 mmol), 4-
methylphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 23 °C, afforded after work-up and chromatography the title compound 
in 92 % yield (33.7 mg). Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 8.1 Hz, 2H), 
7.25 (d, J = 7.2 Hz, 2H), 7.17 – 7.09 (m, 2H), 6.82 (dt, J = 7.4, 1.2 Hz, 1H), 6.76 (dd, J = 8.0, 1.2 
Hz, 1H), 3.73 (s, 2H), 2.40 (s, 3H). 
13
C NMR (125 MHz, CDCl3) δ 143.66, 136.96, 136.64, 
130.58, 129.62, 129.07, 128.42, 127.77, 118.76, 115.68, 21.33. NMR spectroscopic data agreed 
with literature values (Ke et al., 2014). 
2-­(p-­Tolyl)pyridine	  (Scheme	  2)	  
 
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2-­‐chloropyridine	   (0.20	   mmol),	   4-­‐
methylphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  82	  %	  yield	  (27.7	  mg).	  Yellow	  oil.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.68	  (d,	  J	  =	  4.7	  
Hz,	  1H),	  7.89	  (d,	  J	  =	  7.9	  Hz,	  2H),	  7.76	  –	  7.68	  (m,	  2H),	  7.28	  (d,	  J	  =	  7.9	  Hz,	  2H),	  7.20	  (t,	  J	  =	  4.7	  
Hz,	  1H),	  2.41	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  157.49,	  149.61,	  138.94,	  136.66,	  136.63,	  
129.48,	   126.77,	   121.79,	   120.26,	   21.28.	   NMR	   spectroscopic	   data	   agreed	   with	   literature	  
values	  (Iglesias	  et	  al.,	  2012).	  
3-­(6-­Methoxynaphthalen-­2-­yl)pyridine	  (Scheme	  2)	  
 
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2-­‐chloropyridine	   (0.20	   mmol),	   6-­‐
methoxy-­‐2-­‐naphthaleneboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  60	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  97	  %	  yield	  (45.6	  mg).	  Yellow	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.73	  (d,	  J	  
=	  4.4	  Hz,	  1H),	  8.42	  (s,	  1H),	  8.11	  (dd,	  J	  =	  8.6,	  1.6	  Hz,	  1H),	  7.87	  –	  7.82	  (m,	  3H),	  7.78	  (td,	  J	  =	  7.7,	  
1.6	  Hz,	  1H),	  7.25	  –	  7.22	  (m,	  1H),	  7.21	  –	  7.15	  (m,	  2H),	  3.95	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  
δ	  158.38,	  157.61,	  149.86,	  136.90,	  135.07,	  134.74,	  130.39,	  129.15,	  127.41,	  126.28,	  125.20,	  
122.00,	   120.63,	   119.33,	   105.78,	   55.49.	   NMR	   spectroscopic	   data	   agreed	   with	   literature	  
values	  (Zhang	  et	  al.,	  2015).	  
Methyl	  2-­(p-­tolyl)nicotinate	  (Scheme	  2)	  
 
According to the general procedure, the reaction of methyl 2-chloronicotinate (0.20 mmol), 4-
methylphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
THF (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 75 % yield (34.1 mg). Colorless solid. 
1
H NMR (500 MHz, CDCl3) δ 8.76 (dd, J = 4.7, 1.5 Hz, 
1H), 8.06 (dd, J = 7.8, 1.6 Hz, 1H), 7.45 (d, J = 8.0 Hz, 2H), 7.30 (dd, J = 7.8, 4.8 Hz, 1H), 7.24 
(d, J = 7.8 Hz, 2H), 3.72 (s, 3H), 2.40 (s, 3H). 
13
C NMR (125 MHz, CDCl3) δ 168.92, 158.86, 
151.40, 138.83, 137.92, 137.21, 129.07, 128.56, 126.96, 121.38, 52.52, 21.49. HRMS calcd for 
C14H14NO2 (M
+
 + H) 228.0986, found 228.1019.  NMR spectroscopic data agreed with literature 
values (Galenko et al., 2017).
 
3-­(p-­Tolyl)pyridine	  (Scheme	  2)	  
 
According to the general procedure, the reaction of 3-chloropyridine (0.20 mmol), 4-
methylphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 89 % yield (30.1 mg). Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 8.84 (s, 1H), 8.57 (d, J = 4.9 
Hz, 1H), 7.86 (d, J = 7.9 Hz, 1H), 7.49 (d, J = 8.1 Hz, 2H), 7.35 (dd, J = 7.9, 4.8 Hz, 1H), 7.29 
(d, J = 7.8 Hz, 2H), 2.41 (s, 3H). 
13
C NMR (125 MHz, CDCl3) δ 148.36, 148.34, 138.18, 136.71, 
135.09, 134.27, 129.94, 127.13, 123.65, 21.31. NMR spectroscopic data agreed with literature 
values (Iglesias et al., 2012).
 
3-­(6-­Methoxynaphthalen-­2-­yl)pyridine	  (Scheme	  2)	  
 
According to the general procedure, the reaction of 3-chloropyridine (0.20 mmol), 6-methoxy-2-
naphthaleneboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2  (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 96 % yield (45.1 mg). White solid. 
1
H NMR (500 MHz, CDCl3) δ 8.97 (d, J = 2.2 Hz, 1H), 
8.61 (dd, J = 4.9, 1.6 Hz, 1H), 8.02 – 7.95 (m, 2H), 7.85 (d, J = 8.6 Hz, 1H), 7.81 (d, J = 8.9 Hz, 
1H), 7.68 (dd, J = 8.5, 1.8 Hz, 1H), 7.43 – 7.37 (m, 1H), 7.20 (dd, J = 8.9, 2.5 Hz, 1H), 7.18 (s, 
1H), 3.95 (s, 3H). 
13
C NMR (125 MHz, CDCl3) δ 158.27, 148.44, 148.24, 136.87, 134.59, 
134.29, 133.00, 129.90, 129.23, 127.85, 126.11, 125.62, 123.77, 119.67, 105.73, 55.52. NMR 
spectroscopic data agreed with literature values (Voets et al., 2005).
 
5-­(3,4-­Dimethoxyphenyl)-­1H-­indole	  (Scheme	  2)	  
	  
According	   to	   the	  general	  procedure,	   the	   reaction	  of	  5-­‐chloro-­‐1H-­‐indole	   (0.20	  mmol),	  3,4-­‐
dimethoxyphenylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.25	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  60	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  89	  %	  yield	  (45.1	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.18	  (brs,	  
1H),	  7.82	  (s,	  1H),	  7.43	  (q,	  J	  =	  8.4	  Hz,	  2H),	  7.26	  –	  7.23	  (m,	  1H),	  7.22	  –	  7.15	  (m,	  2H),	  6.96	  (d,	  J	  =	  
8.0	  Hz,	   1H),	   6.61	   (s,	   1H),	   3.97	   (s,	   3H),	   3.93	   (s,	   3H).	   13C	  NMR	   (125	  MHz,	  CDCl3)	   δ	  149.20,	  
148.09,	   135.89,	   135.25,	   133.50,	   128.54,	   124.97,	   121.94,	   119.61,	   119.01,	   111.68,	   111.30,	  
111.07,	  103.10,	  56.17,	  56.09.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Jakab	  
et	  al.,	  2015).	  
2-­(4-­Fluorophenyl)quinoline	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 2-chloroquinoline (0.20 mmol), 4-
fluorophenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 97 % yield (43.3 mg).White solid. 
1
H NMR (500 MHz, CDCl3) δ 8.22 (d, J = 8.6 Hz, 1H), 
8.20 – 8.10 (m, 3H), 7.83 (d, J = 8.6 Hz, 2H), 7.74 (t, J = 7.8 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H), 
7.21 (t, J = 8.1 Hz, 2H). 
13
C NMR (125 MHz, CDCl3) δ 163.94 (d, J
F
 = 249.1 Hz), 156.37, 
148.37, 137.04, 135.96 (d, J
F
 = 3.1 Hz), 129.92, 129.79, 129.54 (d, J
F
 = 8.4 Hz), 127.61, 127.22, 
126.48, 118.76, 115.91 (d, J
F
 = 21.5 Hz). 
19
F NMR (471 MHz, CDCl3) δ -112.52. NMR 
spectroscopic data agreed with literature values (Wu et al., 2015).
 
2,4-­Dimethoxy-­6-­(p-­tolyl)-­1,3,5-­triazine	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 2-chloro-4,6-dimethoxy-1,3,5-triazine (0.20 
mmol), 4-methylphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 
mol%) in EtOH (0.5 M) for 12 h at 23 °C, afforded after work-up and chromatography the title 
compound in 98 % yield (45.3 mg). White solid. 
1
H NMR (500 MHz, CDCl3) δ 8.39 (d, J = 8.2 
Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 4.12 (s, 6H), 2.43 (s, 3H). 
13
C NMR (125 MHz, CDCl3) δ 
175.05, 172.98, 143.69, 132.49, 129.40, 129.18, 55.29, 21.84. NMR spectroscopic data agreed 
with literature values (Li et al., 2013).
 
4-­(4-­(tert-­Butyl)phenyl)-­7-­nitrobenzo[c][1,2,5]oxadiazole	  (Scheme	  2)	  
 
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chloro-­‐7-­‐nitrobenzofurazan	   (0.20	  
mmol),	   4-­‐tert-­‐butylphenylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	  
(0.25	  mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  23	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  
the	  title	  compound	  in	  57	  %	  yield	  (33.9	  mg).	  Yellow	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.59	  
(d,	  J	  =	  7.7	  Hz,	  1H),	  8.02	  (d,	  J	  =	  8.6	  Hz,	  2H),	  7.74	  (d,	  J	  =	  7.7	  Hz,	  1H),	  7.62	  (d,	  J	  =	  8.6	  Hz,	  2H),	  
1.40	  (s,	  9H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  155.27,	  149.83,	  143.52,	  139.00,	  135.01,	  131.18,	  
130.95,	   129.09,	   126.61,	   125.42,	   35.21,	   31.29.	   NMR	   spectroscopic	   data	   agreed	   with	  
literature	  values	  (Singh	  et	  al.,	  2008).	  
3',4'-­Dimethoxy-­4-­formylbiphenyl	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 4-chlorobenzaldehyde (0.20 mmol), 3,4-
dimethoxyphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 97 % yield (46.9 mg). Yellow solid. 
1
H NMR (500 MHz, CDCl3) δ 10.04 (s, 1H), 7.93 (d, J = 
8.2 Hz, 2H), 7.72 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 9.0 Hz, 1H), 7.15 (s, 1H), 6.98 (d, J = 8.4 Hz, 
1H), 3.97 (s, 3H), 3.95 (s, 3H). 
13
C NMR (125 MHz, CDCl3) δ 192.00, 149.78, 149.51, 147.13, 
134.95, 132.65, 130.44, 127.37, 120.13, 111.68, 110.54, 56.18. NMR spectroscopic data agreed 
with literature values (Wang et al., 2015). 
4'-­Methyl-­[1,1'-­biphenyl]-­4-­carboxylic	  acid	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 4-chlorobenzoic acid (0.20 mmol), 4-
methylphenylboronic acid (2 equiv), KOH (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 100 °C, afforded after work-up and chromatography the title compound 
in 90 % yield (38.2 mg). White solid. 
1
H NMR (500 MHz, DMSO-d6) δ 12.93 (s, 1H), 8.00 (d, J 
= 8.6 Hz, 2H), 7.77 (d, J = 8.4 Hz, 2H), 7.63 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 7.9 Hz, 2H), 2.35 
(s, 3H). 
13
C NMR (125 MHz, DMSO-d6) δ 167.15, 144.22, 137.78, 136.10, 129.93, 129.67, 
129.29, 126.77, 126.47, 20.71. NMR spectroscopic data agreed with literature values (Edwards 
et al., 2014).
 
5-­(p-­Tolyl)benzo[d][1,3]dioxole	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 4-chlorotoluene (0.20 mmol), 3,4-
(methylenedioxy)phenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 
mol%) in EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title 
compound in 86 % yield (36.5 mg). White solid. 
1
H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 8.1 
Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H), 7.10 – 7.02 (m, 2H), 6.87 (d, J = 7.9 Hz, 1H), 5.99 (s, 2H), 
2.38 (s, 3H). 
13
C NMR (125 MHz, CDCl3) δ 148.19, 146.95, 138.22, 136.81, 135.73, 129.58, 
126.87, 120.50, 108.67, 107.69, 101.22, 21.20. NMR spectroscopic data agreed with literature 
values (Kamio et al, 2019). 
4-­Hydroxy-­4'-­methylbiphenyl	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 4-chlorotoluene (0.20 mmol), 4-
hydroxyphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 89 % yield (32.8 mg). White solid. 
1
H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.4 Hz, 2H), 
7.44 (d, J = 7.9 Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 4.80 (s, 1H), 2.38 (s, 
3H). 
13
C NMR (125 MHz, CDCl3) δ 154.97, 138.03, 136.56, 134.14, 129.58, 128.33, 126.71, 
115.72, 21.20. NMR spectroscopic data agreed with literature values (Edwards et al., 2014). 
2-­(2,4-­Difluorophenyl)pyridine	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 2-chloropyridine (0.20 mmol), 2,4-
difluorophenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 99 % yield (37.8 mg). Yellow oil. 
1
H NMR (500 MHz, CDCl3) δ 8.76 – 8.66 (m, 1H), 8.06 – 
7.95 (m, 1H), 7.84 – 7.69 (m, 2H), 7.24 – 7.21 (m, 1H), 7.07 – 6.86 (m, 2H). 
13
C NMR (125 
MHz, CDCl3) δ 163.34 (dd, J
F
 = 251.2, 11.6 Hz), 160.72 (dd, J
F
 = 252.2, 12.0 Hz), 152.70, 
149.93, 136.61, 132.27 (dd, J
F
 = 9.6, 4.4 Hz), 124.36 (d, J
F
 = 9.1 Hz), 123.95 (d, J
F
 = 12.8 Hz), 
122.57, 112.03 (dd, J
F
 = 21.3, 2.5 Hz), 104.50 (t, J
F
 = 26.5 Hz). 
19
F NMR (471 MHz, CDCl3) δ -
109.36, -112.97. NMR spectroscopic data agreed with literature values (Bergmann et al, 2018).
 
2,4-­Dimethoxy-­6-­(thiophen-­3-­yl)-­1,3,5-­triazine	  (Scheme	  2)	  
	  
According to the general procedure, the reaction of 2-chloro-4,6-dimethoxy-1,3,5-triazine (0.20 
mmol), 3-thienylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
MeOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 87 % yield (38.8 mg). 
1
H NMR (500 MHz, CDCl3) δ 8.45 (dd, J = 3.0, 1.0 Hz, 1H), 7.87 (dd, 
J = 5.1, 1.0 Hz, 1H), 7.34 (dd, J = 5.1, 3.1 Hz, 1H), 4.07 (s, 6H). 
13
C NMR (126 MHz, CDCl3) δ 
172.89, 171.14, 139.44, 131.72, 127.64, 126.26, 55.22. NMR spectroscopic data agreed with 
literature values (Li et al., 2019). 
3-­(4,6-­Dimethoxy-­1,3,5-­triazin-­2-­yl)benzonitrile	  (Scheme	  2)	  
 
	  According	  to	  the	  general	  procedure,	  the	  reaction	  of	  2-­‐chloro-­‐4,6-­‐dimethoxy-­‐1,3,5-­‐triazine	  
(0.20	  mmol),	  3-­‐cyanophenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  
(0.25	  mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  60	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  
the	  title	  compound	  in	  84	  %	  yield	  (40.7	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.80	  
(t,	  J	  =	  1.4	  Hz,	  1H),	  8.72	  (dt,	  J	  =	  8.0,	  1.4	  Hz,	  1H),	  7.84	  (dt,	  J	  =	  7.7,	  1.4	  Hz,	  1H),	  7.62	  (t,	  J	  =	  7.9	  Hz,	  
1H),	   4.15	   (s,	   6H).	   13C	   NMR	   (125	   MHz,	   CDCl3)	   δ	   173.18,	   173.04,	   136.49,	   135.79,	   133.09,	  
132.84,	   129.60,	   118.40,	   113.14,	   55.66.	   HRMS	   calcd	   for	   C12H11N4O2	   (M+	   +	   H)	   243.0877,	  
found	  243.0851.	  	  
2-­Methoxy-­5-­(p-­tolyl)pyridine	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chlorotoluene	   (0.20	   mmol),	   6-­‐
methoxy-­‐3-­‐pyridinylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.25	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  60	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  97	  %	  yield	  (38.6	  mg).	  Colorless	  oil.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.37	  (d,	  J	  
=	  2.5	  Hz,	  1H),	  7.77	  (dd,	  J	  =	  8.6,	  2.6	  Hz,	  1H),	  7.42	  (d,	  J	  =	  8.1	  Hz,	  2H),	  7.26	  –	  7.23	  (m,	  2H),	  6.81	  
(d,	  J	  =	  8.6	  Hz,	  1H),	  3.98	  (s,	  3H),	  2.40	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  163.58,	  144.92,	  
137.49,	   137.27,	   135.18,	   130.21,	   129.82,	   126.68,	   110.88,	   53.66,	   21.24.	  NMR	   spectroscopic	  
data	  agreed	  with	  literature	  values	  (Liu	  et	  al.,	  2011).	  
tert-­Butyl	  (4-­(quinolin-­2-­yl)phenyl)carbamate	  (Scheme	  3)	  
	  
According	   to	   the	  general	  procedure,	   the	  reaction	  of	  2-­‐chloroquinoline	  (0.20	  mmol),	  4-­‐(N-­‐
Boc-­‐amino)phenylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.25	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  60	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  98	  %	  yield	  (62.8	  mg).White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.19	  (d,	  J	  =	  
8.6	  Hz,	  1H),	  8.14	  (d,	  J	  =	  8.8	  Hz,	  3H),	  7.85	  (d,	  J	  =	  8.6	  Hz,	  1H),	  7.81	  (d,	  J	  =	  8.1	  Hz,	  1H),	  7.71	  (td,	  J	  
=	  7.3,	  1.5	  Hz,	  1H),	  7.57	  –	  7.47	   (m,	  3H),	  6.61	   (brs,	  1H),	  1.55	   (s,	  10H).	   13C	  NMR	  (125	  MHz,	  
CDCl3)	   δ	   156.84,	   152.65,	   148.44,	   139.73,	   136.81,	   134.37,	   129.74,	   128.44,	   127.58,	   127.37,	  
127.19,	   126.18,	   118.75,	   118.56,	   29.86,	   28.52.	   NMR	   spectroscopic	   data	   agreed	   with	  
literature	  values	  (Cashion	  et	  al.,	  2011).	  
4'-­Methyl-­N-­phenyl-­[1,1'-­biphenyl]-­4-­carboxamide	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chloro-­‐N-­‐phenylbenzamide	   (0.20	  
mmol),	  4-­‐methylphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  100	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  93	  %	  yield	  (53.4	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  DMSO-­‐d6)	  δ	  10.27	  
(s,	  1H),	  8.05	  (d,	  J	  =	  8.4	  Hz,	  2H),	  7.84	  –	  7.78	  (m,	  4H),	  7.66	  (d,	  J	  =	  8.2	  Hz,	  2H),	  7.36	  (t,	  J	  =	  7.4	  
Hz,	  2H),	  7.32	  (d,	   J	  =	  7.9	  Hz,	  2H),	  7.11	  (t,	   J	  =	  7.3	  Hz,	  1H),	  2.36	  (s,	  3H).	  13C	  NMR	  (126	  MHz,	  
DMSO-­‐d6)	  δ	  165.13,	  142.98,	  139.19,	  137.58,	  136.17,	  133.37,	  129.63,	  128.58,	  128.31,	  126.71,	  
126.22,	   123.61,	   120.34,	   20.70.	   HRMS	   calcd	   for	   C20H17ON	   (M+	   +	   H)	   288.1383,	   found	  
288.1378.	  	  
3-­Methoxy-­6-­phenylpyridazine	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   3-­‐chloro-­‐6-­‐methoxypyridazine	   (0.20	  
mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  89	  %	  yield	  (33.1	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.01	  (d,	  J	  =	  8.3	  
Hz,	  2H),	  7.79	  (d,	  J	  =	  9.3	  Hz,	  1H),	  7.54	  –	  7.43	  (m,	  3H),	  7.05	  (d,	  J	  =	  9.2	  Hz,	  1H),	  4.19	  (s,	  3H).	  13C	  
NMR	  (125	  MHz,	  CDCl3)	  δ	  164.44,	  155.38,	  136.39,	  129.56,	  129.07,	  127.25,	  126.67,	  117.83,	  
55.04.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Clapham	  et	  al.,	  2008).	  
4'-­Methyl-­[1,1'-­biphenyl]-­4-­carboxamide	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chlorobenzamide	   (0.20	  mmol),	   4-­‐
methylphenylboronic	  acid	  (2	  equiv),	  KOH	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   100	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	   in	  95	  %	  yield	   (40.1	  mg).	  White	   solid.	   1H	  NMR	   (500	  MHz,	  DMSO-­‐d6)	  δ	  8.00	   (s,	  
1H),	  7.95	  (d,	  J	  =	  8.4	  Hz,	  2H),	  7.72	  (d,	  J	  =	  8.4	  Hz,	  2H),	  7.62	  (d,	  J	  =	  8.2	  Hz,	  2H),	  7.37	  (s,	  1H),	  7.29	  
(d,	  J	  =	  7.9	  Hz,	  2H),	  2.35	  (s,	  3H).	  13C	  NMR	  (126	  MHz,	  CDCl3)	  δ	  167.53,	  142.64,	  137.41,	  136.30,	  
132.76,	   129.58	   (d,	   J	   =	   9.3	   Hz),	   128.11,	   126.66	   (d,	   J	   =	   8.5	   Hz),	   126.09,	   20.68.	   NMR	  
spectroscopic	  data	  agreed	  with	  literature	  values	  (Asghar	  et	  al.,	  2017).	  
N-­Methyl-­[1,1'-­biphenyl]-­4-­carboxamide	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chloro-­‐N-­‐methylbenzamide	   (0.20	  
mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  93	  %	  yield	  (39.2	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.84	  (d,	  J	  =	  8.4	  
Hz,	  2H),	  7.63	  (d,	  J	  =	  8.3	  Hz,	  2H),	  7.59	  (d,	  J	  =	  7.0	  Hz,	  2H),	  7.45	  (t,	  J	  =	  7.6	  Hz,	  2H),	  7.38	  (t,	  J	  =	  7.3	  
Hz,	  1H),	  6.38	  (s,	  1H),	  3.03	  (d,	  J	  =	  4.8	  Hz,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  168.10,	  144.24,	  
140.13,	   133.41,	   129.02,	   128.07,	   127.50,	   127.31,	   127.29,	   27.00.	   NMR	   spectroscopic	   data	  
agreed	  with	  literature	  values	  (Rao	  et	  al.,	  2017).	  
N,N-­Dimethyl-­[1,1'-­biphenyl]-­4-­carboxamide	  (Scheme	  3)	  
	  
According	  to	  the	  general	  procedure,	  the	  reaction	  of	  4-­‐chloro-­‐N,N-­‐dimethylbenzamide	  (0.20	  
mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  88	  %	  yield	  (39.6	  mg).	  White	  solid.1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.62	  (d,	  J	  =	  8.2	  
Hz,	  2H),	  7.60	  (d,	  J	  =	  7.4	  Hz,	  2H),	  7.50	  (d,	  J	  =	  8.2	  Hz,	  2H),	  7.45	  (t,	  J	  =	  7.7	  Hz,	  2H),	  7.37	  (t,	  J	  =	  7.3	  
Hz,	   1H),	   3.14	   (s,	   3H),	   3.04	   (s,	   3H).	   13C	  NMR	   (125	  MHz,	   CDCl3)	   δ	   171.59,	   142.56,	   140.46,	  
135.19,	   128.99,	   127.85,	   127.78,	   127.27,	   127.17,	   39.79,	   35.56.	   NMR	   spectroscopic	   data	  
agreed	  with	  literature	  values	  (Asghar	  et	  al.,	  2017).	  
4-­Hydroxy-­4'-­methylbiphenyl	  (Scheme	  3)	  
	  
According to the general procedure, the reaction of 4-chlorophenol (0.20 mmol), 4-
methylphenylboronic acid (2 equiv), K2CO3 (3 equiv) and [(IPr)Pd(µ-Cl)Cl]2 (0.25 mol%) in 
EtOH (0.5 M) for 12 h at 60 °C, afforded after work-up and chromatography the title compound 
in 82 % yield (30.2 mg). White solid. 
1
H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.4 Hz, 2H), 
7.44 (d, J = 7.9 Hz, 2H), 7.22 (d, J = 7.8 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 4.80 (s, 1H), 2.38 (s, 
3H). 
13
C NMR (125 MHz, CDCl3) δ 154.97, 138.03, 136.56, 134.14, 129.58, 128.33, 126.71, 
115.72, 21.20. NMR spectroscopic data agreed with literature values (Edwards et al., 2014). 
N-Methyl-[1,1'-biphenyl]-4-sulfonamide (Scheme 3) 
 
According	  to	  the	  general	  procedure,	  the	  reaction	  of	  4-­‐chloro-­‐N-­‐methylbenzenesulfonamide	  
(0.20	  mmol),	   phenylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.05	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  100	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  98	  %	  yield	  (48.4	  mg).	  White	  solid.1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.94	  (d,	  J	  =	  
8.5	  Hz,	  2H),	  7.73	  (d,	  J	  =	  8.4	  Hz,	  2H),	  7.61	  (d,	  J	  =	  7.4	  Hz,	  2H),	  7.48	  (t,	  J	  =	  7.6	  Hz,	  2H),	  7.42	  (t,	  J	  =	  
7.3	  Hz,	  1H),	  4.64	  (q,	   J	  =	  5.4	  Hz,	  1H),	  2.71	  (d,	   J	  =	  5.4	  Hz,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  
145.81,	   139.42,	   137.51,	   129.19,	   128.62,	   127.89,	   127.45,	   29.52.	   NMR	   spectroscopic	   data	  
agreed	  with	  literature	  values	  (Nordvall	  et	  al.,	  2007).	  
4,7-­Di(thiophen-­2-­yl)benzo[c][1,2,5]thiadiazole	  (Scheme	  3)	  
	  
According	  to	  the	  general	  procedure,	  the	  reaction	  of	  4,7-­‐dibromobenzo[c][1,2,5]thiadiazole	  
(0.20	  mmol),	  2-­‐thienylboronic	  acid	  (3	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.025	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  100	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  98	  %	  yield	  (58.9	  mg).	  Red	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.10	  (dd,	  J	  =	  
3.7,	  1.2	  Hz,	  2H),	  7.84	  (s,	  2H),	  7.45	  (dd,	  J	  =	  5.0,	  1.2	  Hz,	  2H),	  7.21	  (dd,	  J	  =	  5.1,	  3.7	  Hz,	  2H).	  13C	  
NMR	   (125	   MHz,	   CDCl3)	   δ	   152.82,	   139.57,	   128.23,	   127.72,	   127.01,	   126.18,	   125.96.	   NMR	  
spectroscopic	  data	  agreed	  with	  literature	  values	  (Chen	  et	  al.,	  2015).	  
2-­(3,4,5-­Trifluorophenyl)pyrazine	  (Scheme	  3)	  
	  
According	  to	  the	  general	  procedure,	  the	  reaction	  of	  2-­‐chloropyrazine	  (0.20	  mmol),	  (3,4,5-­‐
trifluorophenyl)boronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.0025	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  100	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  84	  %	  yield	  (35.3	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.97	  (d,	  J	  =	  
1.1	  Hz,	  1H),	  8.63	  (t,	   J	  =	  2.0	  Hz,	  1H),	  8.56	  (d,	   J	  =	  2.3	  Hz,	  1H),	  7.75	  –	  7.65	  (m,	  2H).	  13C	  NMR	  
(125	  MHz,	   CDCl3)	   δ	   151.88	   (ddd,	   J	   =	   250.7,	   10.3,	   4.0	  Hz),	   149.62	   (q,	   J	   =	   2.5	  Hz),	   144.40,	  
144.09,	  141.72,	  141.09	  (dt,	  J	  =	  255.6,	  15.3	  Hz),	  132.47	  (td,	  J	  =	  7.5,	  4.5	  Hz),	  111.19	  (dd,	  J	  =	  
17.2,	  5.6	  Hz).	  19F	  NMR	  (471	  MHz,	  CDCl3)	  δ	  -­‐132.84	  (d,	  J	  =	  23.6	  Hz,	  2F),	  -­‐158.00	  (t,	  J	  =	  21.2	  
Hz,	  1F).	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Chen	  et	  al.,	  2015).	  
2-­(6-­Methoxypyridin-­3-­yl)pyrazine	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2-­‐chloropyrazine	   (0.20	   mmol),	   6-­‐
methoxy-­‐3-­‐pyridinylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.05	  
mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  100	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  
title	  compound	  in	  98	  %	  yield	  (36.7	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.99	  (s,	  
1H),	  8.81	  (s,	  1H),	  8.61	  (s,	  1H),	  8.50	  (s,	  1H),	  8.25	  (d,	  J	  =	  8.7	  Hz,	  1H),	  6.88	  (d,	  J	  =	  8.1	  Hz,	  1H),	  
4.01	  (s,	  3H).	   13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  165.38,	  150.87,	  145.88,	  144.42,	  142.96,	  141.54,	  
137.30,	  125.81,	  111.55,	  53.96.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Chen	  
et	  al.,	  2015).	  
3-­(Pyridin-­2-­yl)quinoline	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2-­‐chloropyridine	   (0.20	   mmol),	   3-­‐
quinolineboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	   (0.25	   mol%)	   in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  72	  %	  yield	  (29.7	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  9.55	  (d,	  J	  =	  2.2	  
Hz,	  1H),	  8.78	  (d,	  J	  =	  2.7	  Hz,	  2H),	  8.16	  (d,	  J	  =	  8.4	  Hz,	  1H),	  7.97	  –	  7.89	  (m,	  2H),	  7.85	  (td,	  J	  =	  7.7,	  
1.8	  Hz,	  1H),	  7.75	  (t,	  J	  =	  7.7	  Hz,	  1H),	  7.59	  (t,	  J	  =	  7.5	  Hz,	  1H),	  7.36	  –	  7.30	  (m,	  1H).	  13C	  NMR	  (125	  
MHz,	   CDCl3)	   δ	   155.04,	   150.35,	   149.45,	   148.40,	   137.22,	   134.04,	   132.07,	   130.13,	   129.45,	  
128.67,	   128.03,	   127.19,	   122.97,	   120.97.	   NMR	   spectroscopic	   data	   agreed	   with	   literature	  
values	  (Chen	  et	  al.,	  2015).	  
4,6-­Dimethoxy-­2-­(naphthalen-­1-­yl)pyrimidine	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2-­‐chloro-­‐4,6-­‐dimethoxypyrimidine	  
(0.20	   mmol),	   1-­‐naphthylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐Cl)Cl]2	  
(0.025	   mol%)	   in	   EtOH	   (0.5	   M)	   for	   12	   h	   at	   100	   °C,	   afforded	   after	   work-­‐up	   and	  
chromatography	   the	   title	   compound	   in	   95	  %	   yield	   (50.6	  mg).	  White	   solid.	   1H	  NMR	   (500	  
MHz,	  CDCl3)	  δ	  8.92	  (d,	  J	  =	  8.3	  Hz,	  1H),	  8.19	  (d,	  J	  =	  6.5	  Hz,	  1H),	  7.96	  (d,	  J	  =	  8.2	  Hz,	  1H),	  7.91	  
(d,	  J	  =	  7.5	  Hz,	  1H),	  7.60	  –	  7.49	  (m,	  3H),	  6.09	  (s,	  1H),	  4.06	  (s,	  6H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  
δ	  171.44,	  165.80,	  135.66,	  134.29,	  131.25,	  130.73,	  129.46,	  128.59,	  126.58,	  126.38,	  125.82,	  
125.20,	   88.10,	   54.28.	   NMR	   spectroscopic	   data	   agreed	  with	   literature	   values	   (Chen	   et	   al.,	  
2015).	  
Ethyl	  1-­methyl-­5-­phenyl-­1H-­indole-­2-­carboxylate	  (Scheme	  3)	  
	  
According	   to	   the	  general	  procedure,	   the	   reaction	  of	   ethyl	  5-­‐chloro-­‐1-­‐methyl-­‐1H-­‐indole-­‐2-­‐
carboxylate	   (0.20	  mmol),	   phenylboronic	   acid	   (2	   equiv),	   K2CO3	   (3	   equiv)	   and	   [(IPr)Pd(µ-­‐
Cl)Cl]2	   (0.25	   mol%)	   in	   EtOH	   (0.5	   M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	   work-­‐up	   and	  
chromatography	   the	   title	   compound	   in	   92	  %	   yield	   (51.4	  mg).	  White	   solid.	   1H	  NMR	   (500	  
MHz,	  CDCl3)	  δ	  7.87	  (d,	  J	  =	  1.8	  Hz,	  1H),	  7.67	  –	  7.59	  (m,	  3H),	  7.48	  –	  7.42	  (m,	  3H),	  7.37	  –	  7.31	  
(m,	  2H),	  4.39	  (q,	   J	  =	  7.1	  Hz,	  2H),	  4.11	  (s,	  3H),	  1.43	  (t,	   J	  =	  7.1	  Hz,	  3H).	  13C	  NMR	  (125	  MHz,	  
CDCl3)	   δ	   162.33,	   142.02,	   139.32,	   134.19,	   128.88,	   128.82,	   127.44,	   126.77,	   126.49,	   125.07,	  
120.89,	  110.67,	  110.55,	  60.74,	  31.95,	  14.54.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  
values	  (Chikvaidze	  et	  al.,	  2012).	  
2,4-­di-­tert-­Butyl-­6-­(5-­(4-­(trifluoromethyl)phenyl)-­2H-­benzo[d][1,2,3]triazol-­2-­
yl)phenol	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2,4-­‐di-­‐tert-­‐butyl-­‐6-­‐(5-­‐chloro-­‐2H-­‐
benzo[d][1,2,3]triazol-­‐2-­‐yl)phenol	   (0.20	  mmol),	   4-­‐(trifluoromethyl)phenylboronic	   acid	   (2	  
equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  60	  
°C,	   afforded	   after	  work-­‐up	   and	   chromatography	   the	   title	   compound	   in	   95	  %	   yield	   (88.5	  
mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  11.71	  (s,	  1H),	  8.32	  (d,	  J	  =	  2.3	  Hz,	  1H),	  8.13	  (s,	  
1H),	  8.04	  (d,	  J	  =	  8.9	  Hz,	  1H),	  7.83	  –	  7.75	  (m,	  4H),	  7.73	  (dd,	  J	  =	  8.9,	  1.6	  Hz,	  1H),	  7.45	  (d,	  J	  =	  2.3	  
Hz,	   1H),	   1.53	   (s,	   9H),	   1.41	   (s,	   9H).	   13C	  NMR	   (125	  MHz,	   CDCl3)	   δ	   146.93,	   144.29,	   143.26,	  
142.53,	  141.98,	  139.42,	  138.87,	  130.07	  (q,	   J	  =	  32.8	  Hz),	  127.96,	  127.94,	  126.10	  (q,	   J	  =	  3.8	  
Hz),	  125.55,	  125.31,	  124.34	  (q,	   J	  =	  272.0	  Hz),	  118.35,	  116.32,	  115.84,	  35.88,	  34.77,	  31.66,	  
29.74.	  19F	  NMR	  (471	  MHz,	  CDCl3)	  δ	  -­‐62.47.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  
values	  (Chen	  et	  al.,	  2015).	  
4'-­Methoxy-­3,5-­bis(trifluoromethyl)biphenyl	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   4-­‐chloroanisole	   (0.20	   mmol),	   (3,5-­‐
bis(trifluoromethyl)phenyl)boronic	  acid	   (2	  equiv),	  K2CO3	   (3	  equiv)	  and	   [(IPr)Pd(µ-­‐Cl)Cl]2	  
(0.05	   mol%)	   in	   EtOH	   (0.5	   M)	   for	   12	   h	   at	   100	   °C,	   afforded	   after	   work-­‐up	   and	  
chromatography	   the	   title	   compound	   in	  76	  %	  yield	   (48.7	  mg).	  Colorless	  oil.	   1H	  NMR	  (500	  
MHz,	  CDCl3)	  δ	  7.97	  (s,	  2H),	  7.80	  (s,	  1H),	  7.55	  (d,	  J	  =	  8.5	  Hz,	  2H),	  7.03	  (d,	  J	  =	  8.6	  Hz,	  2H),	  3.88	  
(s,	  3H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  160.49,	  143.04,	  132.18	  (q,	  J	  =	  33.2	  Hz),	  130.77,	  128.52,	  
126.79	  (q,	  J	  =	  3.9	  Hz),	  123.59	  (q,	  J	  =	  272.6	  Hz),	  120.34	  (q,	  J	  =	  3.7	  Hz),	  114.85,	  55.59.	  19F	  NMR	  
(471	  MHz,	  CDCl3)	  δ	  -­‐62.87.	  NMR	  spectroscopic	  data	  agreed	  with	  literature	  values	  (Chen	  et	  
al.,	  2015).	  
tert-­Butyl	  2-­(4,6-­dimethoxypyrimidin-­2-­yl)-­1H-­pyrrole-­1-­carboxylate	  (Scheme	  3)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   2-­‐chloro-­‐4,6-­‐dimethoxypyrimidine	  
(0.20	   mmol),	   (1-­‐(tert-­‐butoxycarbonyl)-­‐1H-­‐pyrrol-­‐2-­‐yl)boronic	   acid	   (2	   equiv),	   K2CO3	   (3	  
equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  EtOH	  (0.5	  M)	  for	  12	  h	  at	  60	  °C,	  afforded	  after	  
work-­‐up	  and	  chromatography	  the	  title	  compound	  in	  87	  %	  yield	  (53.1	  mg).	  Colorless	  oil.	  1H	  
NMR	  (500	  MHz,	  CDCl3)	  δ	  7.34	  –	  7.28	  (m,	  1H),	  6.78	  –	  6.72	  (m,	  1H),	  6.23	  (t,	  J	  =	  3.0	  Hz,	  1H),	  
5.93	  (s,	  1H),	  3.95	  (s,	  6H),	  1.46	  (s,	  9H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  171.13,	  159.50,	  149.12,	  
133.17,	  124.96,	  118.01,	  110.60,	  87.73,	  83.68,	  54.09,	  27.84.	  NMR	  spectroscopic	  data	  agreed	  
with	  literature	  values	  (Chen	  et	  al.,	  2015).	  
Isopropyl	   2-­(4-­([1,1'-­biphenyl]-­4-­carbonyl)phenoxy)-­2-­methylpropanoate	   (Scheme	  
4)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   Fenofibrate	   (0.20	   mmol),	  
phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  i-­PrOH	  
(0.5	  M)	  for	  12	  h	  at	  60	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	  the	  title	  compound	  in	  
90	  %	  yield	  (72.4	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.84	  (d,	  J	  =	  8.2	  Hz,	  2H),	  7.80	  
(d,	  J	  =	  8.8	  Hz,	  2H),	  7.69	  (d,	  J	  =	  8.4	  Hz,	  2H),	  7.65	  (d,	  J	  =	  7.5	  Hz,	  2H),	  7.48	  (t,	  J	  =	  7.7	  Hz,	  2H),	  
7.40	  (t,	  J	  =	  7.3	  Hz,	  1H),	  6.89	  (d,	  J	  =	  8.8	  Hz,	  2H),	  5.10	  (hept,	  J	  =	  6.3	  Hz,	  1H),	  1.67	  (s,	  6H),	  1.21	  
(d,	   J	   =	   6.3	  Hz,	   6H).	   13C	  NMR	   (125	  MHz,	   CDCl3)	   δ	   195.29,	   173.32,	   159.66,	   144.93,	   140.20,	  
136.92,	  132.13,	  130.88,	  130.55,	  129.08,	  128.22,	  127.41,	  127.03,	  117.34,	  79.51,	  69.46,	  25.52,	  
21.67.	  HRMS	  calcd	  for	  C26H27O4	  (M+	  +	  H)	  403.1904,	  found	  403.1922.	  	  
1-­(4-­Fluorophenyl)-­4-­(4-­hydroxy-­4-­(4'-­methoxy-­[1,1'-­biphenyl]-­4-­yl)piperidin-­1-­
yl)butan-­1-­one	  (Scheme	  4)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   Haloperidol	   (0.20	   mmol),	   4-­‐
methoxyphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (5	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  
in	   EtOH	   (0.5	  M)	   for	   12	   h	   at	   60	   °C,	   afforded	   after	  work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  93	  %	  yield	  (83.2	  mg).	  Green	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.08	  –	  7.98	  (m,	  
2H),	  7.59	  –	  7.46	  (m,	  6H),	  7.13	  (t,	  J	  =	  8.4	  Hz,	  2H),	  6.96	  (d,	  J	  =	  8.3	  Hz,	  2H),	  3.84	  (s,	  3H),	  2.99	  (t,	  
J	  =	  7.1	  Hz,	  2H),	  2.83	  (d,	  J	  =	  11.2	  Hz,	  2H),	  2.60	  –	  2.45	  (m,	  4H),	  2.10	  (t,	  J	  =	  11.0	  Hz,	  2H),	  2.01	  (p,	  
J	  =	  6.1	  Hz,	  2H),	  1.75	  (d,	  J	  =	  13.5	  Hz,	  2H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  198.48,	  165.75	  (d,	  J	  =	  
254.4	  Hz),	   159.27,	   146.82,	   139.61,	   133.78	   (d,	   J	   =	   3.0	  Hz),	   133.36,	   130.82	   (d,	   J	   =	   9.2	  Hz),	  
128.16,	  126.70,	  125.10,	  115.73	  (d,	   J	  =	  21.8	  Hz),	  114.34,	  71.23,	  57.96,	  55.46,	  49.55,	  38.42,	  
36.41,	  21.93.	   19F	  NMR	  (471	  MHz,	  CDCl3)	  δ	   -­‐105.68.	  HRMS	  calcd	   for	  C28H31FNO3	   (M+	   +	  H)	  
448.2282,	  found	  448.2313.	  	  
2-­(5-­Methoxy-­2-­methyl-­1-­(4'-­methyl-­[1,1'-­biphenyl]-­4-­carbonyl)-­1H-­indol-­3-­
yl)acetic	  acid	  (Scheme	  4)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   Indomethacin	   (0.20	   mmol),	   4-­‐
methylphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (5	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.025	  mol%)	  
in	  EtOH	  (0.5	  M)	   for	  12	  h	  at	  100	  °C,	  afforded	  after	  work-­‐up	  and	  chromatography	   the	   title	  
compound	  in	  83	  %	  yield	  (68.6	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  DMSO-­‐d6)	  δ	  12.37	  (s,	  
1H),	  7.86	  (d,	  J	  =	  8.3	  Hz,	  2H),	  7.76	  –	  7.66	  (m,	  4H),	  7.33	  (d,	  J	  =	  7.9	  Hz,	  2H),	  7.05	  (d,	  J	  =	  2.5	  Hz,	  
1H),	  6.97	  (d,	  J	  =	  8.9	  Hz,	  1H),	  6.70	  (dd,	  J	  =	  9.0,	  2.5	  Hz,	  1H),	  3.76	  (s,	  3H),	  3.68	  (s,	  2H),	  2.37	  (s,	  
3H),	  2.26	  (s,	  3H).	  13C	  NMR	  (125	  MHz,	  DMSO-­‐d6)	  δ	  172.62,	  169.10,	  155.88,	  144.67,	  138.52,	  
136.18,	   135.68,	   134.18,	   131.06,	   130.82,	   130.57,	   130.21,	   127.30,	   127.11,	   114.89,	   113.53,	  
111.70,	  102.07,	  55.87,	  30.05,	  21.21,	  13.60.	  HRMS	  calcd	   for	  C26H24NO4	   (M+	  +	  H)	  414.1700,	  
found	  414.1726.	  	  
	  
N,N-­Dimethyl-­3-­(2-­phenyl-­10H-­phenothiazin-­10-­yl)propan-­1-­amine	  (Scheme	  4)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   Chlorpromazine	   hydrochloride	   (0.20	  
mmol),	  phenylboronic	  acid	  (2	  equiv),	  K2CO3	  (4	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   100	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  95	  %	  yield	  (68.5	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.54	  (d,	  J	  =	  6.9	  
Hz,	  1H),	  7.43	  (t,	  J	  =	  7.7	  Hz,	  2H),	  7.35	  (t,	  J	  =	  7.3	  Hz,	  1H),	  7.23	  –	  7.11	  (m,	  4H),	  7.09	  (d,	  J	  =	  1.8	  
Hz,	  1H),	  6.93	  (t,	  J	  =	  7.6	  Hz,	  2H),	  4.00	  (t,	  J	  =	  6.9	  Hz,	  2H),	  2.49	  (t,	  J	  =	  7.1	  Hz,	  2H),	  2.24	  (s,	  6H),	  
2.03	  (p,	  J	  =	  7.0	  Hz,	  2H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  145.78,	  145.23,	  141.07,	  140.87,	  128.90,	  
127.77,	   127.64,	   127.52,	   127.44,	   127.14,	   125.32,	   124.58,	   122.72,	   121.58,	   115.86,	   114.66,	  
57.24,	  45.55,	  45.51,	  25.13.	  HRMS	  calcd	  for	  C23H25N2S	  (M+	  +	  H)	  361.1738,	  found	  361.1752.	  	  
N-­(4-­(N-­(Cyclohexylcarbamoyl)sulfamoyl)phenethyl)-­4-­methoxy-­4'-­methyl-­[1,1'-­
biphenyl]-­3-­carboxamide	  (Scheme	  4)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   Glibenclamide	   (0.20	   mmol),	   4-­‐
methylphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (0.25	  mol%)	  in	  
EtOH	   (0.5	   M)	   for	   12	   h	   at	   100	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  76	  %	  yield	  (83.6	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  8.41	  (d,	  J	  =	  2.6	  
Hz,	  1H),	  7.99	  (t,	  J	  =	  5.8	  Hz,	  1H),	  7.88	  (d,	  J	  =	  8.1	  Hz,	  2H),	  7.65	  (dd,	  J	  =	  8.6,	  2.6	  Hz,	  1H),	  7.48	  (d,	  
J	  =	  8.1	  Hz,	  2H),	  7.40	  (d,	  J	  =	  8.1	  Hz,	  2H),	  7.22	  (d,	  J	  =	  7.8	  Hz,	  2H),	  6.98	  (d,	  J	  =	  8.6	  Hz,	  1H),	  6.44	  
(d,	  J	  =	  8.0	  Hz,	  1H),	  3.80	  (s,	  3H),	  3.79	  –	  3.74	  (m,	  2H),	  3.62	  –	  3.52	  (m,	  1H),	  3.03	  (t,	  J	  =	  6.9	  Hz,	  
2H),	  2.37	  (s,	  3H),	  1.80	  (d,	   J	  =	  8.7	  Hz,	  2H),	  1.65	  –	  1.58	  (m,	  2H),	  1.57	  –	  1.50	  (m,	  1H),	  1.28	  –	  
1.24	   (m,	   2H),	   1.17	   –	   1.08	   (m,	   3H).	   13C	  NMR	   (125	  MHz,	   CDCl3)	   δ	   165.75,	   156.79,	   151.05,	  
145.89,	   138.14,	   137.08,	   136.88,	   134.46,	   131.23,	   130.47,	   129.82,	   129.63,	   127.53,	   126.71,	  
121.25,	   112.02,	   56.17,	   49.17,	   40.74,	   35.71,	   33.04,	   25.43,	   24.66,	   21.18.	   HRMS	   calcd	   for	  
C30H36N3O5S	  (M+	  +	  H)	  550.2370,	  found	  550.2418.	  	  
	  (2S,6'R)-­2',4,6-­Trimethoxy-­6'-­methyl-­7-­(p-­tolyl)-­3H-­spiro[benzofuran-­2,1'-­
cyclohexan]-­2'-­ene-­3,4'-­dione	  (Scheme	  4)	  
	  
According	   to	   the	   general	   procedure,	   the	   reaction	   of	   (+)-­‐Griseofulvin	   (0.20	   mmol),	   4-­‐
methylphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (3	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  (1	  mol%)	  in	  t-­‐
BuOH	   (0.5	  M)	   for	   12	   h	   at	   100	   °C,	   afforded	   after	   work-­‐up	   and	   chromatography	   the	   title	  
compound	  in	  62	  %	  yield	  (50.6	  mg).	  White	  solid.	  1H	  NMR	  (500	  MHz,	  CDCl3)	  δ	  7.37	  (d,	  J	  =	  8.0	  
Hz,	  2H),	  7.24	  (d,	  2H),	  6.16	  (s,	  1H),	  5.49	  (s,	  1H),	  4.01	  (s,	  3H),	  3.90	  (s,	  3H),	  3.60	  (s,	  3H),	  3.10	  –	  
3.03	  (m,	  1H),	  2.77	  –	  2.68	  (m,	  1H),	  2.39	  (s,	  3H),	  2.39	  –	  2.33	  (m,	  1H),	  0.97	  (d,	  J	  =	  6.7	  Hz,	  3H).	  
13C	   NMR	   (125	   MHz,	   CDCl3)	   δ	   197.53,	   193.51,	   171.95,	   171.83,	   166.46,	   158.62,	   137.34,	  
130.65,	   129.00,	   127.93,	   107.56,	   104.72,	   104.47,	   89.87,	   88.92,	   56.67,	   56.57,	   56.28,	   40.24,	  




According	   to	   the	   general	   procedure,	   the	   reaction	   of	   Chloroquine	   diphosphate	   salt	   (0.20	  
mmol),	  3,4-­‐dimethoxyphenylboronic	  acid	  (2	  equiv),	  K2CO3	  (5	  equiv)	  and	  [(IPr)Pd(µ-­‐Cl)Cl]2	  
(0.025	   mol%)	   in	   EtOH	   (0.5	   M)	   for	   12	   h	   at	   100	   °C,	   afforded	   after	   work-­‐up	   and	  
chromatography	   the	   title	   compound	   in	   89	  %	   yield	   (75.1	  mg).	  White	   solid.	   1H	  NMR	   (500	  
MHz,	  CDCl3)	  δ	  8.53	  (d,	  J	  =	  5.4	  Hz,	  1H),	  8.16	  (d,	  J	  =	  1.9	  Hz,	  1H),	  7.81	  (d,	  J	  =	  8.7	  Hz,	  1H),	  7.64	  
(dd,	  J	  =	  8.7,	  1.9	  Hz,	  1H),	  7.32	  –	  7.26	  (m,	  2H),	  6.97	  (d,	  J	  =	  8.1	  Hz,	  1H),	  6.41	  (d,	  J	  =	  5.4	  Hz,	  1H),	  
5.27	  (d,	  J	  =	  6.3	  Hz,	  1H),	  3.95	  (s,	  3H),	  3.93	  (s,	  3H),	  3.74	  (p,	  J	  =	  6.3	  Hz,	  1H),	  2.55	  (q,	  J	  =	  7.1	  Hz,	  
4H),	  2.47	  (t,	  J	  =	  6.8	  Hz,	  2H),	  1.82	  –	  1.71	  (m,	  1H),	  1.71	  –	  1.56	  (m,	  3H),	  1.32	  (d,	  J	  =	  6.4	  Hz,	  3H),	  
1.02	  (t,	  J	  =	  7.1	  Hz,	  6H).	  13C	  NMR	  (125	  MHz,	  CDCl3)	  δ	  151.46,	  149.41,	  149.11,	  149.09,	  149.03,	  
141.39,	  133.21,	  126.91,	  123.61,	  120.24,	  119.67,	  117.73,	  111.63,	  110.52,	  98.97,	  56.11,	  56.08,	  
52.67,	   48.36,	   46.89,	   34.66,	   23.84,	   20.41,	   11.42.	   HRMS	   calcd	   for	   C26H36N3O2	   (M+	   +	   H)	  
422.2802,	  found	  422.2821.	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